Call Girls Shahdol Just Call 8250077686 Top Class Call Girl Service Available
Slides naqvi
1. Predictive Role of CarotidPredictive Role of Carotid
Intima-Media ThicknessIntima-Media Thickness
Tasneem Z Naqvi MD, FRCP, FACC, FASE, RVT
Associate Professor of Clinical Medicine UCLA
Cedars-Sinai Medical Center
Los Angeles, CA
2. How Good Is NCEP III At Predicting MI?How Good Is NCEP III At Predicting MI?
JACC 2003:41 1475-9JACC 2003:41 1475-9 (Slide from J. Rumberger)(Slide from J. Rumberger)
222 patients with 1222 patients with 1stst
acute MI, no prior CADacute MI, no prior CAD
men <55 y/o (75%), women <65 (25%), no DMmen <55 y/o (75%), women <65 (25%), no DMQualify for RxQualify for Rx
Not-Qualify for RxNot-Qualify for Rx
RiskRisk
>20%/>20%/
10 yrs.10 yrs.
RiskRisk
10-20%/10-20%/
10 yrs.10 yrs.
RiskRisk
<10%/<10%/
10 yrs.10 yrs.
NCEP GoalNCEP Goal
LDL<100LDL<100
NCEP GoalNCEP Goal
LDL<160LDL<160
NCEP GoalNCEP Goal
LDL<130LDL<130
6%6% 6%6%
TotalTotal
12%12%
8%8% 10%10%
TotalTotal
18%18%
61%61%
9%9%
TotalTotal
70%70%
88% of these “young” patients who suffered a88% of these “young” patients who suffered a
first Myocardial Infarction were in thefirst Myocardial Infarction were in the
Low to Intermediate “risk” category accordingLow to Intermediate “risk” category according
To Framingham Risk AssessmentTo Framingham Risk Assessment andand
would have been missed as trulywould have been missed as truly
““High Risk” individuals who shouldHigh Risk” individuals who should
have been treated “aggressively”have been treated “aggressively”
4. Age as a Risk Factor: You Are asAge as a Risk Factor: You Are as
Old asOld as
Your ArteriesYour Arteries
Both EBCT and carotid sonography offer the
opportunity to modify the age factor according to
direct measurements of plaque burden
Grundy SM. Am J Cardiol 1999;83:1455-1457
5.
6.
7. Cohn JN and McVeigh GE et al
The Pathogenesis of CardiovascularThe Pathogenesis of Cardiovascular
DiseaseDisease
12. Association of IMT and Plaque withAssociation of IMT and Plaque with
Risk FactorsRisk Factors
Edinburgh Artery Study, UK 1156 60-79 0.79, 0.85 IMT: Fibrinogen, blood viscosity in men
Vascular Aging (EVA) Study 1271 59-71 0.65, 0.69 IMT & plaque: age, SBP, cholesterol, DM
Bruneck Study, Italy 888 40-79 --------- Plaque: age, SBP, DBP, LDL cholesterol, insulin.
Rotterndam Study, Netherlands1000+ 69 0.76, 0.81 IMT: age, SBP, BMI (men), smoking (men)
Suita Study, Japan 1445 50-79 0.89, 0.92 IMT & plaque: age, SBP, smoking (men)
cholesterol, glucose
San Daniele Project, Italy 1348 18-99 --------- IMT & plaque: age, BP, smoking, alcohol, HDL
Cardiovascular Health Study 5176 65+ 0.96, 1.04 IMT: age, SBP, smoking, cholesterol, DM
Atherosclerosis Risk in Comm. 772, 12841 45-64 0.60, 0.66 IMT & plaque: age, SBP, DBP, BMI
smoking, cholesterol, income, education
Kourpio Ischaemic Heart 1224 42-60 -------- IMT & plaque: age, DM, SBP, smoking, LDL,
Disease (KIHD) h/o IHD, serum copper, education, income,
manual occupation
MONICA Project, Germany 1338 25-65 -------- Plaque in men: age, cholesterol, DM, h/o IHD
Seven Countries Study, 182 70-89 1.5 Plaque: smoking and cholesterol
Finland
Study N Age IMTccaM Associations
Ebrahim et al Stroke. 1999;30:841-850
13. Simon A et al. Journal of Hypertension 2002, 20:159±169
14. Paul TK: Am J Med Sci, Volume 330(3). 2005.105-110
Bogalusa Heart Study: Risk Factors and IMT
in Young Adults (24-43y)
0
5
10
15
20
25
30
35
40
45
0 1 2 =>3
Bottom 5th
Top 5th
Number of Risk Factors
Prevalence(%)
IMT
15. Li, S. et al. JAMA 2003;290:2271-2276.
Carotid IMT Represents Cumulative LDL-C Burden From
Childhood to Adulthood (25-37 yrs)
16. Järvisalo MJ et al Circulation. 2001;104:2943-2947
16 44 28
IMT Is Associated With Risk Factors in Children
17. Eric de Groot et al Circulation. 2004;109[suppl III]:III-33–III-38
IMT Progression in Familial Hypercholesterolemia
18. Distribution of IMT in the General Population (AXA Study)
Gariepy J et al Arterioscler Thromb Vasc Biol 1998; 4: 584–590
(AXA Study)
19. 0.64 0.65
0.74
0.8
0.75 0.78
0.93
0.98
0.85 0.85
1.09
1.14
0
0.2
0.4
0.6
0.8
1
1.2
1.4
LCCA RCCA L Bulb R Bulb
0.72 0.71
0.84 0.850.83 0.84
1.03 1.04
0.99 1.01
1.31
1.21
0
0.2
0.4
0.6
0.8
1
1.2
1.4
LCCA RCCA L Bulb R Bulb
0.61 0.61
0.73 0.75
0.71 0.71
0.88 0.91
0.81
0.93
1.09
1.16
0
0.2
0.4
0.6
0.8
1
1.2
1.4
LCCA RCCA L Bulb R Bulb
0.7
0.66
0.82
0.66
0.8 0.77
1.06
0.77
0.93 0.9
1.23
0.9
0
0.2
0.4
0.6
0.8
1
1.2
1.4
LCCA RCCA L Bulb R Bulb
Bar graph of 75th percentiles of common carotid artery and carotid artery bifurcation IMT in men and women stratified according to
decade of age (45 yrs green, 55 yrs dark blue, 65 years light blue and race. Adapted from Howard G, et al Stroke 1993; 24:1297-1304.).
Black Women (n=2219) Black Men (n=1391)
White Women (5377) White Men (n=4837)
Carotid IMT in the General Population (ARIC)45 yrs
55 yrs
65 yrs
21. Prevalence of Cardiovascular Disease for Specific
Degrees of Carotid Atherosclerosis
Lancet 2000;356:279-84
Differences in Risk Factors, Atherosclerosis and
Cardiovascular Disease Between Ethnic Groups in Canada
23. Adams MR et al Circulation 1995;92:2127-34
Carotid IMT and Prevalent Coronary Artery Disease
24.
25. Carotid IMT/Plaque and Incident CVD in Population-Based Prospective Studies
Study
n (%
male)
Age
(yrs)
Follow-
up
(yrs)
Carotid US
Parameters
Endpoint Results
KIHD 1257 (100) 42-60 2 Normal
CCA IMT >1.0
mm
Non-stenotic
plaque Stenotic
plaque
MI No increased risk with IMT>1.0 mm
Plaque: RR: 4.1 (1.8-9.2)
KIHD 2181 (100) 42-60 4 Same as above MI IMT >1.0 mm: RR: 2.1 (1.1-4.1)*
Non-stenotic plaque: RR: 3.4 (1.9-
5.9)*
Stenotic plaque: RR: 6.3 (3.1-12.6)*
Chieti 2000 (56) 30-70 6 Same as above Incidence of MI,
angina, CVA,
PVD
IMT >1.0 mm: 5.5%
Plaque: 18.4%
Stenotic plaque: 42%
ARIC 12841 (43) 45-64 5.2 Mean IMT of 6
sites
MI, CHD death IMT<1.0 mm vs. IMT≥1.0 mm
Women: HRR: 2.62 (1.55-4.46)**
Men: HRR: 1.20 (0.81-1.77)**
Rotterdam Study 1470 (38) ≥55 2.7 SD increase in
CCA IMT
MI Women: OR: 1.26 (0.89-1.79)**
Men: OR: 1.25 (0.91-1.72)**
IMT>0.908 mm: OR: 1.44 (0.65-
3.16)**
CHS 4476 (39) >65 6.2 Quintiles or SD of
maximum CCA
and/or ICA IMT
MI, Stroke Increasing risk per quintile or SD**
26. Relation of Carotid Intima-media Thickness
with CV Events in Asymptomatic Subjects
Simon: J Hypertens, Volume 20(2).February 2002.159-169
27. 0
2
4
6
8
10
12
14
<0.6 0.6-0.7 0.7-0.8 0.8-1.0 >1.0
Women
Men
Coronary Heart Disease IncidenceCoronary Heart Disease Incidence
Rates in ARIC per 1000 Person-Rates in ARIC per 1000 Person-
YearsYears
Adjusted for Age and Race
Carotid Artery Intima-Media Thickness (mm)
28. 0
1
2
3
4
5
6
7
Women Men
CIMT
LDL
Atherosclerosis Risk in Communities (ARIC) StudyAtherosclerosis Risk in Communities (ARIC) Study
(12,800 subjects, 45-64 years of age at baseline)(12,800 subjects, 45-64 years of age at baseline)
Hazard Rate Ratio (highest to lowest tertile) for a Clinical EventHazard Rate Ratio (highest to lowest tertile) for a Clinical Event
within 5.2 Years of Follow-Up forwithin 5.2 Years of Follow-Up for CIMTCIMT andand LDLLDL Levels inLevels in
Women and MenWomen and Men
HRR
34. Prognostic Significance of Carotid and Femoral
Artery Plaques in Patients with Stable Angina
Held C et al. Eur Heart J, Vol. 22, issue 1, January 2001
35. Held C et al. Eur Heart J, Vol. 22, issue 1, January 2001
Prognostic Significance of Carotid and Femoral
Artery Plaques in Patients with Stable Angina
36. H.N. Hodis, W.J. Mack, L. LaBree, R.H. Selzer, C.R. Liu, C.H. Liu and S.P. Azen , The role of carotid arterial intima-media
thickness in predicting clinical coronary events. Ann Intern Med 128 (1998), pp. 262–269
Effect of IMT Progression
38. Meta-analysis of Mortality Associated with Abdominal Aortic Aneurysms in the
Abdominal Aortic Aneurysm Screening Trials
The U.S. Preventive Services Task Force (USPSTF) recommends one-time
screening for abdominal aortic aneurysm by abdominal ultrasonography for
men
between the ages of 65 and 75 who have ever smoked
39. SignificanceSignificance ofof BaselineBaseline CIMTCIMT
From the text of the AHA Prevention Conference V
Writing Group III on Noninvasive Tests of
Atherosclerotic Burden: (Circulation 2000;101:e16-e22)
“More than 5 published studies found that carotid IMT
measurement is a viable predictor of the presence of
coronary atherosclerosis and its clinical sequelae. Thus,
carotid IMT defined by noninvasive B-mode ultrasound
has been shown to be an independent risk factor for CHD
events and stroke.”
40. Clinical Assessment of CIMTClinical Assessment of CIMT
…In asymptomatic persons >45 years old, carefully
performed carotid ultrasound examinations with IMT
measurement can add incremental information to
traditional risk factor assessment. In experienced
laboratories, this test can now be considered for
further clarification of CHD risk
assessment at the request of a physician.”
41. 53 yr old male
T chol: 251
HDL 53
LDL 167
TG 70
Framingham risk:11%
Clinical Utility of Carotid IMT
46. Age as a Risk Factor: You Are asAge as a Risk Factor: You Are as
Old asOld as
Your ArteriesYour Arteries
There are no acceptable published charts for age-related
distributions for either coronary calcium scores or carotid
intimalmedial thicknesses. Until these charts become
available, adjustment of age scores according to measured
plaque burden will not be possible
Measurements made in different laboratories must correlate
consistently with those from which age-related distributions of
plaque burden were derived
Grundy SM. Am J Cardiol 1999;83:1455-1457
47. LIMITATIONSLIMITATIONS
Methodological criteria taken into account for
measuring
carotid IMT
Image acquisition Segment: CCA, bulb, ICA, right/left
Wall: far, near
Type of measure Mean of several maximum
measures (from 2 to 12)
Mean of randomly selected measures (from 3 to 5)
Mean of measures over 1 cm (> 100)
Measurement Methods
48. Goal and ChallengesGoal and Challenges
Confidently establish an independent role in
cardiovascular risk prediction over and above
clinical risk including consideration of newer
serologic risk markers such as C-reactive protein
To demonstrate that atherosclerosis imaging
techniques favorably impact cardiovascular
outcomes in a cost-effective manner
Comparison with newer imaging modalities such
as MRI and cine CT for coronary calcification
Incorporate important demographic subgroups
including women and ethnic minorities
49. The 1st National SHAPE Guideline
• Coronary Calcium Score
• Carotid IMT+
• Coronary Calcium Score
• Carotid IMT+
(-) Test(-) Test (+) Test(+) Test
•Lifestyle
Modification
•RF Reduction
•EHAC Education
•Reassess in
5 year
•Lifestyle
Modification
•RF Reduction
•EHAC Education
•Reassess in
5 year
•Aggressive Lifestyle
Modifications
•Target LDL <100mg/dl
•Intensive EHAC
Education
•Reassess in
5 years
•Aggressive Lifestyle
Modifications
•Target LDL <100mg/dl
•Intensive EHAC
Education
•Reassess in
5 years
•No Treatment
•EHAC
Education
•Reassess
in 5 years
•No Treatment
•EHAC
Education
•Reassess
in 5 years
•Aggressive Lifestyle
Modifications
•Target LDL<130 mg/dl
•Intensive EHAC
Education
•Reassess in
5 years
•Aggressive Lifestyle
Modifications
•Target LDL<130 mg/dl
•Intensive EHAC
Education
•Reassess in
5 years
All Asymptomatic Males ≥45y and Females ≥55y with no History of CVDAll Asymptomatic Males ≥45y and Females ≥55y with no History of CVD
CCS >400 and
CCS ≥ 100th% & >90th%
CIMT>1.1 mm, or
Positive Plaque
CCS >400 and
CCS ≥ 100th% & >90th%
CIMT>1.1 mm, or
Positive Plaque
(–)(–) (+)(+)
AngiographyAngiography
•Target LDL<70
mg/dl
•Intensive EHAC
Education
•Follow Existing
Guidelines
•Target LDL<70
mg/dl
•Intensive EHAC
Education
•Follow Existing
Guidelines
+ Pending standard practice guidelines.+ Pending standard practice guidelines.
+1 RF+1 RF +2 or More RFs+2 or More RFs
CCS <75th% & <100th%
CIMT <75th% & <1mm
and Negative Plaque
CCS <75th% & <100th%
CIMT <75th% & <1mm
and Negative Plaque
Very High RiskVery High Risk
CCS >75th % or >100th%
CIMT>75th% or >1mm or
Positive Plaque
CCS >75th % or >100th%
CIMT>75th% or >1mm or
Positive Plaque
CRP>4mg/lCRP>4mg/l
EHAC: Early Heart Attack CareEHAC: Early Heart Attack Care
(Screening for Heart Attack Prevention and Education -SHAPE)(Screening for Heart Attack Prevention and Education -SHAPE)
•Target LDL<70 mg/dl
•Rest Follows High Risk
Group
•Target LDL<70 mg/dl
•Rest Follows High Risk
Group
CRP: C Reactive ProteinCRP: C Reactive Protein
CIMT: Carotid Intima-Media ThicknessCIMT: Carotid Intima-Media Thickness
CCS: Coronary Calcium ScoreCCS: Coronary Calcium Score
*Exclude Very-Low-Risk Group*Exclude Very-Low-Risk Group
* Known cases of cholesterol <200 mg/dl + blood pressure <120/80 mmHg + no diabetes + no
smoking + no family history, and no metabolic syndrome
* Known cases of cholesterol <200 mg/dl + blood pressure <120/80 mmHg + no diabetes + no
smoking + no family history, and no metabolic syndrome
Moderately
High Risk
Moderately
High Risk Ischemia
Test
Ischemia
Test
Test for AtherosclerosisTest for Atherosclerosis
RF: Risk Factors (high cholesterol, high blood pressure,
diabetes, smoking, family history, metabolic syndrome)
RF: Risk Factors (high cholesterol, high blood pressure,
diabetes, smoking, family history, metabolic syndrome)
CVD: angina, heart attack, stroke, peripheral arterial diseaseCVD: angina, heart attack, stroke, peripheral arterial disease
High RiskHigh Risk
Lower RiskLower Risk Moderate RiskModerate Risk
(see SHAPE report for details)(see SHAPE report for details)
CCS>0
CIMT detectable
CCS>0
CIMT detectable
CCS=0
CIMT undetectable
CCS=0
CIMT undetectable
Positive Plaque: Focal protrusion >1.5 mmPositive Plaque: Focal protrusion >1.5 mm
50. SummarySummary
Carotid Intima Media Thickness (CIMT) is associated with
known and UNKNOWN CV risk risk factors
CIMT and carotid plaques are markers of subclinical
atherosclerosis and help in the early identification of
presymptomatic individuals
CIMT predicts prevalent CV disease
CIMT predicts incident CV disease
Presence of plaque provides incremental risk
Abdominal ultrasound for AAA in men > 65 yrs is cost
effective and decreases mortality from AAA rupture
51. Peri and post menopausal women
Family history of premature CHD
African American
Smoker
Total cholesterol level > 240 mg/dl
HDL cholesterol <40 mg/dl
Blood pressure >140/90 mm Hg
Diabetes mellitus
More than 20 pounds overweight
Leading a sedentary lifestyle
Depression?
Who Should Be Tested?
52.
53.
54. 0.81 0.77
0.99
1.17
0.96
1.03
1.47
1.161.12 1.06
1.69
1.83
0
0.5
1
1.5
2
2.5
LCCA RCCA L Bulb R Bulb
0.72 0.73
1.08
1.18
0.91 0.88
1.34 1.38
1.04 1.03
1.89
2.27
0
0.5
1
1.5
2
2.5
LCCA RCCA L Bulb R Bulb
0.89 0.83
1.16
1.36
1 0.96
1.78 1.77
1.3 1.25
1.92
2.5
0
0.5
1
1.5
2
2.5
LCCA RCCA L Bulb R Bulb
Black Women (n=2219) Black Men (n=1391)
0.9 0.89
1.31 1.36
1.07 1.05
1.74
1.67
1.43
1.3
2.3
2.16
0
0.5
1
1.5
2
2.5
LCCA RCCA L Bulb R Bulb
White Women (5377) White Men (n=4837)
Bar graph of 95th percentiles of common carotid artery and carotid artery bifurcation IMT in men and women stratified according to
decade of age (45 yrs green, 55 yrs dark blue, 65 years light blue and race. Adapted from Howard G, et al Stroke 1993; 24:1297-1304.).
Distribution of IMT in the General Population (ARIC)
45 yrs
55 yrs
55 yrs
55. Am J Cardiol 2000;85:949–952
IMT Predicts Prevalent CAD
56.
57.
58. Komorovsky CR et al Heart 2005;91;819-820
Prognostic significance of characteristics of carotid plaques in patients with acute coronary syndromes
59. CSMC ExperienceCSMC Experience
N=35 13F 22 M
Age 52±16 yrs 54±11 yrs
Weight 147 ±29 lbs 197 ±41 lbs
SBP 125±9 mm Hg 128±11 mm Hg
DBP 72±10 mm Hg 76±9 mm Hg
T chol 186 ±41 198 ±45 mg/dl
LDL chol 104 ±44 125 ±40 mg/dl
HDL chol 67 ±9 42 ±6 mg/dl
60. 0.65 0.67
0.74
0.933
0.71 0.7
0.85 0.875
0
0.2
0.4
0.6
0.8
1
1.2
1.4
LCCA RCCA L Bulb R Bulb
Bar graph of mean far wall common carotid artery and carotid artery bifurcation IMT in men and women
Distribution of IMT in the General Population
0.62
0.68
0.73
0.79
0.68 0.66
0.83 0.84
0
0.2
0.4
0.6
0.8
1
1.2
1.4
LCCA RCCA L Bulb R Bulb
Mean IMT Far Wall (CSMC)
50th Centile of Far Wall Mean IMT (ARIC)
Female
Male
64. Table 2. Association [Odds Ratio (95% CI)] of Intima-Media Thickness With Myocardial Infarction and Stroke1
IMT With Myocardial Infarction, mm
<0.75 0.75-0.821 0.822-0.907 0.908 <0.75 0.75-0.821
All events
n 34 17 18 29 13 19
Model I2
1.0 0.97 (0.52-1.80) 1.09 (0.58-2.74) 1.72 (0.96-3.10) 1.0 2.61 (1.26-5.45
Model II 1.0 0.96 (0.51-1.79) 1.07 (0.58-2.02) 1.65 (0.91-2.99) 1.0 2.28 (1.08-4.84
Model III 1.0 0.86 (0.43-1.70) 1.10 (0.57-2.17) 1.25 (0.64-2.44) 1.0 1.87 (0.86-4.11
First events3
n 23 11 13 21 10 13
Model I 1.0 0.98 (0.46-2.07) 1.29 (0.62-2.65) 2.32 (1.17-4.64) 1.0 2.27 (0.99-5.22
Model III 1.0 0.78 (0.35-1.77) 1.19 (0.55-2.58) 1.44 (0.65-3.16) 1.0 1.83 (0.78-4.33
Bots, M. L. et al. Circulation 1997;96:1432-1437
65. Carotid Intima-Media Thickness Is Only Weakly
Correlated With the Extent and Severity of
Coronary Artery Disease
Mark R. Adams, MBBS, FRACP; Akihiro Nakagomi, MD; Anthony Keech,
MBBS, MEpidemiol, FRACP; Jacqui Robinson, RN; Robyn McCredie, BSc;
Brian P. Bailey, MBBS, FRACP; S. Ben Freedman, MBBS, PhD, FRACP;
David S. Celermajer, MBBS, PhD, FRACP
Circulation 1995;92:2127-34
67. Figure 3. Scatterplot of IMT
versus
A: the number of major coronary
arteries with ≥70% stenosis in 350
consecutively studied subjects,
B: the modified Gensini score of
coronary disease,
C: the extent score of coronary disease.
A
B C
Circulation 1995;92:2127-34
68. Figure 4. Receiver operating characteristic plot for use of carotid IMT to predict the absence
of significant coronary disease (mean IMT predicting no vessels with ≥70% stenosis). The
"line of chance" is the diagonal line, reflecting a test with no predictive value; the receiver
operating characteristic plot is the solid line. There is no value of IMT on this curve, which
demonstrates both high (>80%) sensitivity and specificity simultaneously, suggesting that
IMT is not a clinically useful test for predicting the absence of significant CAD.
Circulation 1995;92:2127-34
69. Discussion
In this study of patients undergoing elective coronary
angiography, IMT of the far wall of the CCAs was significantly
but only weakly correlated with the extent and severity of CAD,
with r<.30and r2
<.10. These data have important implications for
theinterpretation of the large number of trials that have used or are
using carotid IMT measurement as a noninvasive marker of the
atherosclerotic process.15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35
36
The reasons for this relatively poor correlation may be
biological, because intima-media thickening is a different
pathological process to atheromatous plaque formation1 10
and
there are different risk factor influences on the carotid and
coronary circulations and technical factors may make
contributions, for example, the accuracy of B-mode ultrasonic
measurement ofsubmillimeter distances.
Circulation 1995;92:2127-34
70. Discussion
……….
……….
Technical Issues: Ultrasonic Resolution
The theoretical axial resolution of high-frequency external vascular
ultrasound with 7- to 10-MHz transducers is approximately 0.1 mm,
but in practice most ultrasound machines use pulses with multiple
cycles and have an axial resolution of approximately 0.3 mm.2 16 38
The difference between "control" and "risk factor" groups in many
observational studies of carotid IMT has been <0.2 mm.13 15 16
Although the precision to detect differences between group mean
values is higher than for individual measurements, most studies
measure IMT in individuals to the nearest 0.1 mm or even 0.01 mm,
which may be beyond the limits of resolution of the ultrasound used.
Circulation 1995;92:2127-34
72. Validation of Carotid Artery Wall Thickness as a Surrogate of
Cardiovascular Disease
Lancet 2000;356:279-84
Differences in Risk Factors, Atherosclerosis and
Cardiovascular Disease Between Ethnic Groups in Canada
73. Predictors of Cardiovascular Disease by
Multivariate Logistic Regression
Lancet 2000;356:279-84
Differences in Risk Factors, Atherosclerosis and
Cardiovascular Disease Between Ethnic Groups in Canada
74. Conventional and Novel Risk Factors For
Cardiovascular Disease
Lancet 2000;356:279-84
Differences in Risk Factors, Atherosclerosis and
Cardiovascular Disease Between Ethnic Groups in Canada
75. Conventional and Novel Risk Factors ForConventional and Novel Risk Factors For
Cardiovascular DiseaseCardiovascular Disease
Lancet 2000;356:279-84
Differences in Risk Factors, Atherosclerosis and
Cardiovascular Disease Between Ethnic Groups in Canada
76.
77. 0.79
1
1.09
0.9
1.06
1.37
0.73
0.9
1.04
0.86
0.98
1.28
0
0.4
0.8
1.2
1.6
45 55 65
Age (years)
IMT(mm)
Black Women Black Men White Women White Men
Bar graph of 95th percentiles of common carotid artery IMT in men and women stratified according to
decade of age and race. Howard G, et al Stroke 1993; 24:1297-1304.).
Distribution of IMT in the General Population
78. H.N. Hodis, W.J. Mack, L. LaBree, R.H. Selzer, C.R. Liu, C.H. Liu and S.P. Azen , The role of carotid arterial intima-media
thickness in predicting clinical coronary events. Ann Intern Med 128 (1998), pp. 262–269
79. Characteristics of Screening Trials for Abdominal Aortic Aneurysm
Characteristic MASS22
Western
Australia
Study23,32
Viborg
County
Study21
Chichester
Study, Men20
Chichester
Study, Women20
Location United
Kingdom
Australia Denmark United
Kingdom
United Kingdom
Age, y 65–74 65–83 65–73 65–80 65–80
Total patients randomly
assigned to treatment, n
67,800 38,704 12,658 6433 9342
Mean followup, y 4.1 3.62
5.1 2.5 2.6
Invited for screening, n 33,839 19,352 6339 3205 4682
Attended screening, % 80 63 69 73 65
Uninvited controls, n 33,961 19,352 6319 3228 4660
Outcomes ascertained, % 99 993
100 NR NR
Quality Good Fair Fair Fair Fair
1.
Values in parentheses are reference numbers. All studies except the Chichester study included only men. MASS= Multicentre Aneurysm
Screening Study; NR= not reported..
Median followup. 3.
Provided by the study investigators.
Fleming C et al. Ann Intern Med 2005;142:203-11
85. Significance of CIMTSignificance of CIMT ProgressionProgression
“Several clinical intervention or prevention trials
have illustrated the ability of carotid B-mode
ultrasound imaging to monitor changes in IMT
over time… In such plaque monitoring studies,
quantitative quality control of sonographers …
and readers… was found to be critical..., this
method would be useful in follow-up of patients
treated for plaque progression or regression.”
99. (35.7%) were reclassified as higher risk
(14.3%) were reclassified as lower risk
Integrating carotid intima-media thickness measurements
with global coronary risk assessment. Stein JH et al Clin Cardiol. 2004 Jul;27(7):388-92.
Vascular Age Concept
101. 150 200 300
No CHD
CHD
20/100 40/100 90/100
35% of CHD
occurs in people
with T chol <200 mg/dl
Total Cholesterol mg/dl
The incidence of MI in relation to total cholesterol levels in the Framingham Study, 26 year follow-up.
102. Comparing Framingham Risk Factor ScoreComparing Framingham Risk Factor Score
and Coronary Artery Disease (CAD)and Coronary Artery Disease (CAD)
0
2
4
6
8
10
12
14
NO YES
CAD
FraminghamScore
p = 0.447
BAD (Fayad ZA, Mani V, Fuster V et al.) 2005
103. 76.5 Million76.5 Million
AmericansAmericans
Have High CRPHave High CRP
Correlates of Elevated C-Reactive Protein Among Adults in the United States:
Findings From the 1999-2000 National Health and Nutrition Examination Survey
106. Who Should Be Tested?
Intermediate Likelihood of CHD, FRI 10-20
FRI has limitations, does not include family history, obesity,
triglycerides, diabetes, sedentary life style, CRP
and other emerging risk factors
Carotid IMT is an end result of exposure to all known and
unknown risk factors
108. FundamentalsFundamentals
1. A propagating ultrasonic pulse is reflected
at a boundary between two different
tissues.
2. The direction of the incident pulse must
be perpendicular to the boundary if the
transducer is to detect the reflected pulse.
3. The ultrasonic pulse has a finite duration
or pulse length.
109. FundamentalsFundamentals
4. The total time required for the “leading edge”
of the ultrasonic pulse to travel from the
transducer face to each boundary and back again
is measured by the ultrasound system.
5. We assume that we know the approximate speed
of sound (1540 m/s) with which the ultrasonic
pulse travels in the intervening tissue or
medium.
110. FundamentalsFundamentals
6. The distance from the transducer face to
each boundary can be calculated from
distance = (speed x total time) / 2 .
7. The distance between the “leading edges”
of two boundaries can be calculated from
the difference in the distances calculated
for each of the two boundaries.
111. Paul TK: Am J Med Sci, Volume 330(3).September
2005.105-110
Bogalusa Heart Study: Risk Factors and IMT in Young Adults (24-43y)
112.
113. Hodis, H. N. et. al. Ann Intern Med 1998;128:262-269
Multivariate Associations of Lipid Levels and Coronary Arterial and Common
Carotid Arterial Measures of Atherosclerosis with Risk for Clinical Coronary
Events*
118. Combined Risk of Heart Attack and Stroke (ARIC)
0
5
10
15
20
25
0.4 0.5 0.6 0.7 0.8 0.9 1 1.1 1.2 1.3
Mean CIMT (mm)
Risk(%per10years)
119. Population-Based Prospective Studies of the Prognostic Utility of Carotid Ultrasonography (USG)
Study
Population n (% male) Age
(yrs)
Race Follow
-up
(yrs)
Carotid USG
Parameters
Endpoint Results
KIHD2
Eastern
Finland
1257 (100) 42,48,5
4,60
C 2 Normal
CCA IMT >1.0 mm
Non-stenotic plaque
Stenotic plaque
MI No increased risk with IMT>1.0 mm
Plaque: RR: 4.1 (1.8-9.2)
KIHD3
Eastern
Finland
2181 (100) 42,48,5
4,60
C 4 Same as above MI IMT >1.0 mm: RR: 2.1 (1.1-4.1)*
Non-stenotic plaque: RR: 3.4 (1.9-
5.9)*
Stenotic plaque: RR: 6.3 (3.1-12.6)*
Chieti4
Italy 2000 (56) 30-70 C 6 Same as above Incidence of MI,
angina, CVA,
PVD
IMT >1.0 mm: 5.5%
Plaque: 18.4%
Stenotic plaque: 42%
ARIC5
United
States
12841 (43) 45-64 C, A-A 5.2 Mean IMT of 6 sites MI, CHD death IMT<1.0 mm vs. IMT≥1.0 mm
Women: HRR: 2.62 (1.55-4.46)**
Men: HRR: 1.20 (0.81-1.77)**
Rotterdam Study6
Holland 1470 (38) ≥55 C 2.7 SD increase in CCA
IMT
MI Women: OR: 1.26 (0.89-1.79)**
Men: OR: 1.25 (0.91-1.72)**
IMT>0.908 mm: OR: 1.44 (0.65-
3.16)**
CHS1
United
States
4476 (39) >65 C, A-A 6.2 Quintiles or SD of
maximum CCA and/or
ICA IMT
MI, Stroke Increasing risk per quintile or SD**
Abbreviations: KIHD=Kuopio Ischaemic Heart Disease Risk Factor Study, ARIC=Atherosclerosis Risk in Communities, CHS=Cardiovascular Health Study.
DM=diabetes mellitus, na=not available, MI=myocardial infarction, C=Caucasian A-A=African-American, RR=relative risk, HRR=hazard rate ratio,
OR=odds ratio, SD=standard deviation
*Results of Cox regression with CVD risk factors not reported, but results said to still be significant.
**Adjusted for CVD risk factors
120.
121.
122. Table 1. Ultrasound Arterial Morphology Classification
: Localized wall thickening and increased density involving all ultrasonic layers. Intima-media thickness >2 mm.
Clas
s
Ultrasound Morphology Score
*
I Normal: Three ultrasonic layers (intima-media, adventitia, and periadventitia) clearly separated. No disruption of lumen-intima
interface for at least 3.0 cm, and/or initial alterations (lumen-intima interface disruption at intervals of <0.5 cm).
2
II Intima-media granulation: Granular echogenicity of deep, normally unechoic intimal-medial layer and/or increased intima-media
thickness (>1 mm).
4
III Plaque without hemodynamic disturbance 6
IV Stenotic plaque: As in III, but with hemodynamic stenosis on duplex scanning (sample volume in the center of the lumen),
indicating stenosis >50%.
8
The score is relative to one artery. The patient's score is the sum of the scores of all four arteries. Hemodynamic disturbance is defined as moderate
spectral broadening (downstroke of systole); systolic window present; diastolic window reduced and/or absent. Ratio a-b/a<0.5, where a is the
peak systolic velocity and b, the first peak end-systolic velocity
128. ChallengesChallenges
Near wall, far wall or both
Short Axis, long axis
2D or M-mode
Lumen yes or no
Multiple angles or not
CCA, Bulb, ICA
One side or both sides
Methodological
Issues
129. ChallengesChallenges
Implementing in Clinical Practice
Sonographer training
Time factor in a labor intensive technique
Incorporate into cardiology fellowship
training
Reimbursement
Ability to do online measurements
132. ChallengesChallenges
Risk of a New Technology
Performed by unskilled personnel
Quality
Unnecessary testing and treatment
Who should undergo IMT as opposed to coronary
calcium?
Diabetics, women, blacks, young and the
elderly
133. What motivates our patientsWhat motivates our patients
more?more?
A scan with some white stuff
Or
Fat inside the artery?
134. 53 yr old male
T chol: 251
HDL 53
LDL 167
TG 70
Framingham risk:11%
137. Survival Curves for Degree ofSurvival Curves for Degree of
AtherosclerosisAtherosclerosis
The Rotterdam Study, Circulation 2004;109:1083-94
Hazard ratios were equally high for carotid plaques (1.83 [1.27 to 2.62], severe versus no atherosclerosis),
carotid IMT (1.95 [1.19 to 3.19]), and aortic atherosclerosis (1.94 [1.30 to 2.90])
and slightly lower for lower-extremity atherosclerosis (1.59 [1.05 to 2.39])
FRI has limitations, does not include family history, obesity,
triglycerides, diabetes, sedentary life style, CRP
and other emerging risk factors
Preventing Myocardial Infarction in the Young
Adult in the First Place: How Do the National
Cholesterol Education Panel III Guidelines Perform?
Kwame O. Akosah, MD, Ana Schaper, PHD, Christopher Cogbill, BA, Paul Schoenfeld, MD
La Crosse, Wisconsin
OBJECTIVES The purpose of this study was to investigate the utility of the new National Cholesterol
Education Program (NCEP) III guidelines in a group of young adults.
BACKGROUND These guidelines have been hailed as an improvement in their potential to identify individuals
at risk for coronary heart disease (CHD) complications. Compared with the NCEP II, the
new guidelines will increase the number of patients who qualify for medical management.
However, the effectiveness of these guidelines to identify young adults at risk for a cardiac
event is yet to be studied.
METHODS A retrospective review of clinical data from young adults (age 55 years for men and 65
years for women) hospitalized for acute myocardial infarction over a three-year period was
conducted. Patients with a history of CHD or CHD equivalent were excluded. Using the
NCEP III guidelines, we calculated a 10-year risk for coronary events on all patients.
RESULTS A total of 222 patients met criteria for inclusion. The mean age was 50 years and 25% were
women. Mean lipid levels were all within the normal range; however, rates of smoking and
obesity were high. When the 10-year risk of these patients was stratified by the number of risk
factors and low-density lipoprotein cholesterol level, only 25% met criteria to qualify for
pharmacotherapy. For women in this population, only 18% met criteria for treatment.
CONCLUSIONS The new guidelines offer multiple new features but have a tendency to underappreciate the
risk for disease in young adults. To improve performance in young adults, statistical
adjustments may be necessary. (J Am Coll Cardiol 2003;41:1475–9)
There were 56 (25%) women in this
study population. A comparison between genders for lipid
values was determined using the Student t test. The mean
total cholesterol was the same in both genders (190 44
mg/dl and 190 43 mg/dl in women and men, respectively).
The mean HDL cholesterol level was 46 14 mg/dl for
women and 42 15 mg/dl for men and not statistically
different (p 0.5). Women had a statistically lower mean
LDL cholesterol level (117 40 mg/dl vs. 129 38 mg/dl,
p 0.014). In contrast, the mean triglyceride level was
significantly higher in women than men (160 76 mg/dl
vs. 140 77 mg/dl, p 0.043). Whereas 35 men (21%)
had no known traditional cardiovascular risk factors, all of
the women had at least one risk factor, excluding high HDL
cholesterol. Counting high HDL cholesterol as a negative
risk factor, four women qualified as having no risk factors.
Also, using the Student t test, the mean number of major
risk factors present was higher in women than men (2.9 vs.
1.5 risk factors, p 0.001). In spite of the higher mean
number of risk factors present, no woman in this study had
a calculated risk of 20%. Only 5% of women in this study
had risk scores for probability of 10-year event between 10%
and 20%. Thus, the majority of women had a 10-year risk of
Less than 10%. Overall, 82% of women did not score high enough
to be identified for pharmacotherapy by the new guidelines,
compared with 59% of men.
Common carotid artery, carotid bifurcation (bulb) and external and internal carotid arteries of a healthy 50 year old male showing normal carotid intima-media thickness (A) and common carotid artery and carotid bifurcation of a 55 year old African American female showing diffuse thickening of intimal-medial layer along the near (near the skin) and far wall (furthest from skin) of common carotid artery and carotid bifurcation. CCA=common carotid artery, ECA=external carotid artery, ICA=internal carotid artery.
Intima±media thickness: a new tool for diagnosis and
treatment of cardiovascular risk
Alain Simon, Je roÃme Gariepy, Gilles Chironi, Jean-Louis Megnien and
Jaime Levenson
Increased intima±media thickness (IMT) is a non-invasive
marker of early arterial wall alteration, which is easily
assessed in the carotid artery by B-mode ultrasound, and
more and more widely used in clinical research. Methods
of IMT measurement can be categorized by two
approaches: (i) measurement at multiple extracranial
carotid sites in near and far walls and (ii) computerized
measurement restricted to the far wall of the distal
common carotid artery. Because IMT re¯ects global
cardiovascular risk, its normal value might be better
de®ned in terms of increased risk rather than in terms of
statistical distribution within a healthy population. The
available epidemiological data indicate that increased IMT
(at or above 1 mm) represents a risk of myocardial
infarction and/or cerebrovascular disease. Close
relationships have been shown between: (i) most
traditional cardiovascular risk factors; (ii) certain emerging
risk factors such as lipoproteins, psychosocial status,
plasma viscosity, or hyperhomocysteinemia; and (iii)
various cardiovascular or organ damages such as white
matter lesion of the brain, left ventricular hypertrophy,
microalbuminuria or decreased ankle to brachial systolic
pressure index. Thus, IMT gives a comprehensive picture
of the alterations caused by multiple risk factors over time
on arterial walls. Prospective primary and secondary
prevention studies have also shown that increased IMT is a
powerful predictor of coronary and cerebrovascular
complications (risk ratio from 2 to 6) with a higher
predictive value when IMT is measured at multiple
extracranial carotid sites than solely in the distal common
carotid artery. Therapeutic double-blind trials have shown
that lipid-lowering drugs, such as resin and overall
statines, and to a lesser extent antihypertensive drugs,
such as calcium antagonists, may have a bene®cial effect
on IMT progression in asymptomatic or in coronary
patients. However, methodological standardization of IMT
measurement still needs to be implemented before routine
measurement of IMT can be proposed in clinical practice
as a diagnostic tool for stratifying cardiovascular risk in
primary prevention and for aggressive treatment decision.
It can be anticipated however, that the presence of
increased carotid IMT in one individual with intermediate
cardiovascular risk would lead to his classi®cation into the
high-risk category and thus in¯uence the aggressiveness
of risk factor modi®cations. J Hypertens 20:159±169 &
2002 Lippincott Williams & Wilkins.
35. Skoglund-Andersson C, Tang R, Bond MG, de Faire U, Hamsten A,
Karpe F. LDL particle size distribution is associated with carotid intimamedia
thickness in healthy 50-year-old men. Arterioscler Thromb Vacc
Biol 1999; 10:2422±2430.
36 Terry JG, Howard G, Mercuri M, Bond MG, Crouse JR 3rd. Apolipoprotein
E polymorphism is associated with segment-speci®c extracranial
carotid artery intima-media thickening. Stroke 1996; 10:1755±1759.
37 Schreiner PJ, Heiss G, Tyroler HA, Morrisett JD, Davis CE, Smith R.
Race and gender differences in the association of Lp(a) with carotid
artery wall thickness. The Atherosclerosis Risk in Communities (ARIC)
Study. Arterioscler Thromb Vasc Biol 1996; 16:471±478.
38 Fukumoto M, Shoji T, Emoto M, Kawagishi T, Okuno Y, Nishizawa Y.
Antibodies against oxidized LDL and carotid artery intima-media thickness
in a healthy population. Arterioscler Thromb Vasc Biol 2000;
20:703±707.
39 Matthews KA, Owens JF, Kuller LH, Sutton-Tyrrell K, Jansen-McWilliams
L. Are hostility and anxiety associated with carotid atherosclerosis in
healthy postmenopausal women? Psychosom Med 1998; 60:
633±638.
40 Diez-Roux AV, Nieto FJ, Tyroler HA, Crum LD, Szklo M. Social inequalities
and atherosclerosis. The atherosclerosis risk in communities study.
Am J Epidemiol 1995; 141:960±972.
41 Lee AJ, Mowbray PI, Lowe GD, Rumley A, Fowkes FG, Allan PL. Blood
viscosity and elevated carotid intima-media thickness in men and
women: the Edinburgh Artery Study. Circulation 1998; 97:
1467±1473.
42 Levenson J, Gariepy J, Del-Pino M, Salomon J, Denarie N, Simon A.
Association of plasma viscosity and carotid thickening in a French
working cohort. Am J Hypertens 2000; 13:753±758.
43 Lindberg G, Rastam L, Lundblad A, Sorlie PD, Folsom AR. The
association between serum sialic acid and asymptomatic carotid atherosclerosis
is not related to antibodies to herpes type viruses or
Chlamydia pneumoniae. The Atherosclerosis Risk in Communities
(ARIC) Study Investigators. Int J Epidemiol 1997; 26:1386±1391.
44 Demirovic J, Nabulsi A, Folsom AR, Carpenter MA, Szklo M, Sorlie PD,
Barnes RW. Alcohol consumption and ultrasonographically assessed
carotid artery wall thickness and distensibility. The Atherosclerosis Risk
in Communities (ARIC) Study Investigators. Circulation 1993;
88:2787±2793.
45 Rohde LE, Lee RT, Rivero J, Jamacochian M, Arroyo LH, Briggs W, et
al. Circulating cell adhesion molecules are correlated with ultrasoundbased
assessment of carotid atherosclerosis. Arterioscler Thromb Vasc
Biol 1998; 18:1765±1770.
46 Lamont D, Parker L, White M, Unwin N, Bennett SM, Cohen M, et al.
Risk of cardiovascular disease measured by carotid intima-media thickness
at age 49±51: lifecourse study. BMJ 2000; 320:273±278.
47 Bizbiz L, Bonithon-Kopp C, Ducimetiere P, Berr C, Alperovitch A, Robert
L. Relation of serum elastase activity to ultrasonographically assessed
carotid artery wall lesions and cardiovascular risk factors. The EVA
study. Atherosclerosis 1996; 120:47±55.
48 Nomura E, Kohriyama T, Yamaguchi S, Kajikawa H, Nakamura S.
Association between carotid atherosclerosis and hemostatic markers in
patients with cerebral small artery disease. Blood Coagul Fibrinolysis
1998; 9:55±62.
49 Bensen JT, Li R, Hutchinson RG, Province MA, Tyroler HA. Family
history of coronary heart disease and pre-clinical carotid artery atherosclerosis
in African-Americans and whites: the ARIC study: Atheroscler
Risk Comm Genet Epidemiol 1999; 16:165±178.
50 Schmidt-Trucksass AS, Grathwohl D, Frey I, Schmid A, Boragk R,
Upmeier C, et al. Relation of leisure-time physical activity to structural
and functional arterial properties of the common carotid artery in male
subjects. Atherosclerosis 1999; 145:107±114.
51 Chen L, Patsch W, Boerwinkle E. HindIII DNA polymorphism in the
lipoprotein lipase gene and plasma lipid phenotypes and carotid artery
atherosclerosis. Hum Genet 1996; 98:551±556.
52 Gaeta G, De Michele M, Cuomo S, Guarini P, Foglia MC, Bond MG,
Trevisan M. Arterial abnormalities in the offspring of patients with
premature myocardial infarction. N Engl J Med 2000; 343:840±846.
53 Sass C, Zannad F, Herbeth B, Salah D, Chapet O, Siest G, Visvikis S.
Apolipoprotein E4, lipoprotein lipase C447 and angiotensin-I converting
enzyme deletion alleles were not associated with increased wall
thickness of carotid and femoral arteries in healthy subjects from the
Stanislas cohort. Atherosclerosis.; 199?; 140:89±95.
54 Frost D, Pfohl M, Clemens P, Haring HU, Beischer W. Evaluation of the
insertion/deletion ACE gene polymorphism as a risk factor for carotid
artery intima-media thickening and hypertension in young type 1 diabetic
patients. Diabetes Care 1998; 21:836±840.
55 Kauma H, Paivansalo M, Savolainen MJ, Rantala AO, Kiema TR, Lilja M,
et al. Association between angiotensin converting enzyme gene polymorphism
and carotid atherosclerosis. J Hypertens 1996; 14:1183±
1187.
56 Castellano M, Muiesan ML, Rizzoni D, Beschi M, Pasini G, Cinelli A,
et al. Angiotensin-converting enzyme I/D polymorphism and arterial wall
thickness in a general population. The Vobarno Study. Circulation
1995; 91:2721±2724.
57 Hosoi M, Nishizawa Y, Kogawa K, Kawagishi T, Konishi T, Maekawa K,
et al. Angiotensin-converting enzyme gene polymorphism is associated
with carotid arterial wall thickness in non-insulin-dependent diabetic
patients. Circulation 1996; 94:704±707.
58 Dessi-Fulgheri P, Catalini R, Sarzani R, Sturbini S, Siragusa N,
Guazzarotti F, et al. Angiotensin converting enzyme gene polymorphism
and carotid atherosclerosis in a low-risk population. J Hypertens 1995;
13:1593±1596.
59 McQuillan BM, Beilby JP, Nidorf M, Thompson PL, Hung J. Hyperhomo-
Intima±media thickness Simon et al. 167
cysteinemia but not the C677T mutation of methylenetetrahydrofolate
reductase is an independent risk determinant of carotid wall thickening.
The Perth Carotid Ultrasound Disease Assessment Study. Circulation
1999; 99:2383±238.
60 Bots ML, Launer LJ, Lindemans J, Hofman A, Grobbee DE. Homocysteine,
atherosclerosis and prevalent cardiovascular disease in the
elderly: The Rotterdam Study. J Intern Med 1997; 242:339±347.
61 Rubba P, Mercuri M, Faccenda F, Iannuzzi A, Irace C, Strisciuglio P,
et al. Premature carotid atherosclerosis: does it occur in both familial
hypercholesterolemia and homocystinuria? Ultrasound assessment of
arterial intima-media thickness and blood ¯ow velocity. Stroke 1994;
25:943±950.
62 Megnien JL, Gariepy J, Saudubray JM, Nuoffer JM, Denarie N, Levenson
J, Simon A. Evidence of carotid artery wall hypertrophy in homozygous
homocystinuria. Circulation 1998; 98:2276±2281.
63 Malinow MR, Nieto FJ, Szklo M, Chambless LE, Bond G. Carotid artery
intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic
adults. The Atherosclerosis Risk in Communities Study.
Circulation 1993; 87:1107±1113.
64 Coles KA, Plant AJ, Riley TV, Smith DW, McQuillan BM, Thompson PL.
Lack of association between seropositivity to chlamydia Pneumoniae
and carotid atherosclerosis. Am J Cardiol 1999; 84:825±828.
65 Nieto FJ, Adam E, Sorlie P, Farzadegan H, Melnick JL, Comstock GW,
Szklo M. Cohort study of cytomegalovirus infection as a risk factor for
carotid intimal-medial thickening, a measure of subclinical atherosclerosis.
Circulation 1996; 94:922±927.
66 Sorlie PD, Adam E, Melnick SL, Folsom A, Skelton T, Chambless LE,
et al. Cytomegalovirus/herpesvirus and carotid atherosclerosis: the
ARIC Study. J Med Virol 1994; 42:33±37.
67 Shinozaki K, Hattori Y, Suzuki M, Hara Y, Kanazawa A, Takaki H, et al.
Insulin resistance as an independent risk factor for carotid artery wall
intima media thickening in vasospastic angina. Arterioscler Thromb Vasc
Biol 1997; 17:3302±3310.
68 Haffner SM, D&apos;Agostino R, Mykkanen L, Hales CN, Savage PJ, Bergman
RN, et al. Proinsulin and insulin concentrations in relation to carotid wall
thickness: Insulin Resistance Atherosclerosis Study. Stroke 1998;
29:1498±1503.
69 Fujii K, Abe I, Ohya Y, Onaka U, Tominaga M, Ohmori S, et al.
Association between hyperinsulinemia and intima-media thickness of the
carotid artery in normotensive men. J Hypertens 1997; 15:167±172.
70 Schreiner PJ, Heiss G, Tyroler HA, Morrisett JD, Davis CE, Smith R.
Race and gender differences in the association of Lp(a) with carotid
artery wall thickness. The Atherosclerosis Risk in Communities (ARIC)
Study. Arterioscler Thromb Vasc Biol 1996; 16:471±478.
71 Yamamoto M, Egusa G, Yamakido M. Carotid atherosclerosis and serum
lipoprotein (a) concentrations in patients with NIDDM. Diabetes Care
1997; 20:829±831.
72 Ebrahim S, Papacosta O, Whincup P, Wannamethee G, Walker M,
Nicolaides AN, et al. Carotid plaque, intima media thickness, cardiovascular
risk factors, and prevalent cardiovascular disease in men and
women: the British Regional Heart Study. Stroke 1999; 30:841±850.
73 Thalhammer C, Balzuweit B, Busjahn A, Walter C, Luft FC, Haller H.
Endothelial cell dysfunction and arterial wall hypertrophy are associated
with disturbed carbohydrate metabolism in patients at risk for cardiovascular
disease. Arterioscler Thromb Vasc Biol 1999; 19:
1173±1179.
74 Touboul PJ, Elbaz A, Koller C, Lucas C, Adrai V, Chedru F, Amarenco P.
Common carotid artery intima-media thickness and brain infarction: the
Etude du Pro®l Genetique de l&apos;Infarctus Cerebral (GENIC) case-control
study. The GENIC Investigators. Circulation 2000; 18:313±318.
75 Hashimoto M, Eto M, Akishita M, Kozaki K, Ako J, Iijima K, et al.
Correlation between ¯ow-mediated vasodilatation of the brachial artery
and intima-media thickness in the carotid artery in men. Arterioscler
Thromb Vasc Biol 1999; 19:2795±2800.
76 Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common
carotid intima-media thickness and risk of stroke and myocardial
infarction: the Rotterdam Study. Circulation 1997; 96:1432±1437.
77 Burke GL, Evans GW, Riley WA, Sharrett AR, Howard G, Barnes RW,
et al. Arterial wall thickness is associated with prevalent cardiovascular
disease in middle-aged adults. The Atherosclerosis Risk in Communities
(ARIC) Study. Stroke 1995; 26:386±391.
78 Roman MJ, Saba PS, Pini R, Spitzer M, Pickering TG, Rosen S, et al.
Parallel cardiac and vascular adaptation in hypertension. Circulation
1992; 86:1909±1918.
79 Kawagishi T, Nishizawa Y, Konishi T, Kawasaki K, Emoto M, Shoji T,
et al. High-resolution B-mode ultrasonography in evaluation of atherosclerosis
in uremia. Kidney Int 1995; 48:820±826.
80 Linhart A, Gariepy J, Giral P, Levenson J, Simon A. Carotid artery and
left ventricular structural relationship in asymptomatic men at risk for
cardiovascular disease. Atherosclerosis 1996; 127:103±112.
81 Cuspidi C, Lonati L, Sampieri L, Leonetti G, Zanchetti A. Similarities and
differences in structural and functional changes of left ventricle and
carotid arteries in young borderline hypertensives and in athletes.
J Hypertens 1996; 14:759±764.
82 Cuspidi C, Lonati L, Sampieri L, Pelizzoli S, Pontiggia G, Leonetti G,
Zanchetti A. Left ventricular concentric remodeling and carotid structural
changes in essential hypertension. J Hypertens 1996; 14:
1441±1446.
83 Vingerling JR, Dielemans I, Bots ML, Hofman A, Grobbee DE, de Jong
PT. Age-related macular degeneration is associated with atherosclerosis.
The Rotterdam Study. Am J Epidemiol 1995; 142:404±409
Auperin A, Berr C, Bonithon-Kopp C, Touboul PJ, Ruelland I, Ducimetiere
P, Alperovitch A. Ultrasonographic assessment of carotid wall
characteristics and cognitive functions in a community sample of 59-
to 71-year-olds. The EVA Study Group. Stroke 1996; 27:
1290±1295.
85 Bots ML, de Jong PT, Hofman A, Grobbee DE. Left, right, near or far
wall common carotid intima-media thickness measurements: associations
with cardiovascular disease and lower extremity arterial atherosclerosis.
J Clin Epidemiol 1997; 50:801±807.
86 Nagai Y, Metter EJ, Earley CJ, Kemper MK, Becker LC, Lakatta EG, Fleg
JL. Increased carotid artery intimal-medial thickness in asymptomatic
older subjects with exercise-induced myocardial ischemia. Circulation
1998; 98:1504±1509.
87 Bots ML, van Swieten JC, Breteler MM, de Jong PT, van Gijn J, Hofman
A, Grobbee DE. Cerebral white matter lesions and atherosclerosis in
the Rotterdam Study. Lancet 1993; 341:1232±1237.
88 Rosfors S, Hallerstam S, Jensen-Urstad K, Zetterling M, Carlstrom C.
Relationship between intima-media thickness in the common carotid
artery and atherosclerosis in the carotid bifurcation. Stroke 1998;
29:1378±1382.
Prevalence of multiple risk factors in young adults with IMT in the extreme fifth percentiles: The Bogalusa Heart Study. Risk factors included hypertension, obesity, dyslipidemia, adverse glucose level, and smoking
Cardiovascular Risk Profile of Asymptomatic
Healthy Young Adults with Increased Femoral
Artery Intima-Media Thickness: The Bogalusa
Heart Study
TIMIR K. PAUL, MD, MPH; SATHANUR R. SRINIVASAN, PHD; CHEN WEI, MD, PHD;
SHENGXU LI, MD; AZAD R. BHUIYAN, MD, MPH; M. GENE BOND, PHD;
RONG TANG, MD, MS; GERALD S. BERENSON, MD
ABSTRACT: Background: Femoral artery intima-media
thickness (IMT), like carotid IMT, is a surrogate indicator
of atherosclerotic coronary and peripheral vascular diseases
in middle-aged and older adults. This study examined
the cardiovascular disease risk profile of asymptomatic
young adults with increased femoral artery IMT.
Methods: Femoral artery IMT was measured by B-mode
ultrasonography in 1080 black and white subjects (aged
24-43 years; 71% white, 43% male) enrolled in the
Bogalusa Heart Study. Individuals in the top (n 54)
versus bottom fifth (n 54) percentiles distribution of
femoral IMT were compared for traditional cardiovascular
risk factors profile. Univariate analysis compared the
two groups, t-tests and 2 tests were performed. Results:
The top and bottom fifth percentiles of IMT differed with
respect to age (P 0.001), systolic blood pressure (P
0.05), diastolic blood pressure (P 0.05), total cholesterol
(P 0.01), low-density lipoprotein (LDL) cholesterol
(P 0.001), non-high-density lipoprotein (HDL)
cholesterol (P 0.01) and smoking status (P 0.01). In
terms of prevalence of clinically defined traditional risk
factors, individuals at the top versus bottom fifth percentile
of IMT distribution had significantly higher prevalence
of high LDL cholesterol (130 mg/dL), non-HDL
cholesterol (160 mg/dL), and cigarette smoking. The
odds ratio for individuals with three or more risk factors
versus no risk factors having IMT in the top fifth percentile
was 4.7 (P 0.01). Conclusion: The observed
adverse effect of cardiovascular risk factors on IMT of
femoral artery, a surrogate measure of coronary and
peripheral atherosclerosis, in asymptomatic young individuals
underscores the need for risk factors profiling in
early life. These observations have important implications
in preventive medicine. KEY INDEXING TERMS:
Femoral artery; Intima-media thickness; Risk factors;
Ultrasonography; Peripheral vascular disease. [Am J
Med Sci 2005;330(3):105–110.]
Carotid IMT by Quartile of LDL-C Level Measured in Childhood, Adulthood, and as a Cumulative Burden From Childhood to Adulthood
Figure. Carotid IMT by Quartile of LDL-C Level Measured in Childhood, Adulthood, and as a Cumulative Burden From Childhood to AdulthoodData are mean (95% confidence interval). IMT indicates intima-media thickness; LDL-C, low-density lipoprotein cholesterol. P values for differences among quartiles were adjusted for age, race, and sex. z Scores specific for age, race, and sex were used to define quartiles of LDL-C level. To convert LDL-C to mmol/L, multiply values by 0.0259.
Childhood Cardiovascular Risk Factors and Carotid Vascular Changes in Adulthood The Bogalusa Heart Study
Shengxu Li, MD, MPH; Wei Chen, MD, PhD; Sathanur R. Srinivasan, PhD; M. Gene Bond, PhD; Rong Tang, MD, MS; Elaine M. Urbina, MD; Gerald S. Berenson, MD
JAMA. 2003;290:2271-2276.
ABSTRACT Context Carotid artery intima-media thickness (IMT) is associated with cardiovascular risk factors and is recognized as an important predictive measure of clinical coronary atherosclerosis events in middle-aged and elderly populations. However, information on the association of carotid IMT in young adults with different risk factors measured in childhood, adulthood, or as a cumulative burden of each of the risk factors measured serially from childhood to adulthood is limited.
Objective To examine the association between carotid IMT in young adults and traditional cardiovascular risk factors measured since childhood.
Design, Setting, and Participants A cohort study of 486 adults aged 25 to 37 years from a semirural black and white community in Bogalusa, La (71% white, 39% men), who had at least 3 measurements of traditional risk factors since childhood, conducted between September 1973 and December 1996.
Main Outcome Measure Association of carotid IMT with risk factors, including systolic blood pressure, lipoprotein levels, and body mass index.
Results Male vs female (0.757 mm vs 0.719 mm) and black vs white (0.760 mm vs 0.723 mm) participants had increased carotid IMT (P&lt;.001 for both). In multivariable analyses, significant predictors for being in top vs lower 3 quartiles of carotid IMT in young adults were childhood measures of low-density lipoprotein cholesterol (LDL-C) level (odds ratio [OR], 1.42, corresponding to 1-SD change specific for age, race, and sex; 95% confidence interval [CI], 1.14-1.78) and body mass index (BMI; OR, 1.25; 95% CI, 1.01-1.54); adulthood measures of LDL-C level (OR, 1.46; 95% CI, 1.16-1.82), high-density lipoprotein cholesterol (HDL-C) level (OR, 0.67; 95% CI, 0.51-0.88), and systolic blood pressure (OR, 1.36; 95% CI, 1.08-1.72); and long-term cumulative burden of LDL-C (OR, 1.58; 95% CI, 1.24-2.01) and HDL-C (OR, 0.75; 95% CI, 0.58-0.97) levels measured serially from childhood to adulthood. An increasing trend in carotid IMT across quartiles of LDL-C level measured in childhood was observed, with a mean value of 0.761 mm (95% CI, 0.743-0.780 mm) for those at the top quartile vs 0.724 mm (95% CI, 0.715-0.734 mm) for those in the lower 3 quartiles (P&lt;.001).
Conclusions Childhood measures of LDL-C level and BMI predict carotid IMT in young adults. The prevention implications of these findings remains to be explored
aIMT and cIMT are significantly higher in high-risk
children (both P0.001 compared with controls), but the aIMT is
relatively more thick than the cIMT, resulting in significant differences
in the aIMT/cIMT ratio in high-risk children (paired t tests,
P0.01). Values are meanSEM.
Increased Aortic Intima-Media Thickness
A Marker of Preclinical Atherosclerosis in High-Risk Children
Mikko J. Järvisalo, BM; Laura Jartti, MD; Kirsti Näntö-Salonen, MD, PhD; Kerttu Irjala, MD, PhD;
Tapani Rönnemaa, MD, PhD; Jaakko J. Hartiala, MD, PhD;
David S. Celermajer, PhD, FRACP; Olli T. Raitakari, MD, PhD
Background—Autopsy studies in children have shown that atherosclerotic lesions begin to develop first in the intima of
the aorta. Recent developments in ultrasound techniques have made it possible to visualize the intima-medial thickness
of the abdominal aorta directly (aIMT). Therefore, we examined the feasibility of measuring aIMT in children and
studied its value in distinguishing high-risk children from healthy controls compared with a more established marker of
subclinical atherosclerosis, the common carotid artery intima-medial thickness (cIMT).
Methods and Results—IMTs were measured using high-resolution (13 MHz) ultrasound in 88 children (aged 112 years);
16 had hypercholesterolemia (LDL cholesterol, 5.11.2 mmol/L), 44 had type 1 diabetes (mean duration, 4.43.1
years; LDL cholesterol, 2.30.7 mmol/L), and 28 were healthy (controls; LDL cholesterol, 2.50.8 mmol/L). High-risk
children had significantly increased aIMTs and cIMTs (both P0.001) compared with controls. In controls, aIMT was
similar to cIMT (PNS), but aIMT was higher than cIMT in the children with hypercholesterolemia and diabetes (both
P0.01). Both markers showed excellent and approximately equal between-observer (4%) and between-subject
variation (5%).
Conclusions—Children with hypercholesterolemia and diabetes show increased IMTs compared with healthy controls,
with a relatively greater increase in the aIMT than in the cIMT. Because atherosclerosis begins first in the intima of the
aorta, these data suggest that the aIMT might provide the best currently available noninvasive marker of preclinical
atherosclerosis in children. (Circulation. 2001;104:2943-2947.)
The FH group consisted of 315 subjects (age range, 11 to 67 years; LDL-C 7.2±1.8 mmol/L); the control group consisted of 118 unaffected subjects (age range, 11 to 76 years; LDL-C 3.1±0.8 mmol/L) . Arterial wall thickness progression estimates in persons heterozygous for familial hypercholesterolemia (FH; LDL-C 7.2±2.0 mmol/L; IMT 0.79±0.20 [range, 0.45 to 1.53] mm; red dots) and healthy controls (LDL-C 3.4±0.8 mmol/L; IMT 0.63±0.14 [0.48 to 1.14] mm; blue dots). For the pooled FH (red line) and the pooled control data (blue line), IMT increase was estimated by linear regression (with respective 95% confidence intervals depicted in gray lines). On average, healthy controls reach an IMT of approximately 0.8 mm at age 80, whereas FH subjects reach this value (and, if untreated, often their first cardiovascular symptoms) around the age of 40 years Measurement of Arterial Wall Thickness as a Surrogate
Marker for Atherosclerosis
Eric de Groot, MD, PhD; G. Kees Hovingh, MD; Albert Wiegman, MD; Patrick Duriez, PhD;
Andries J. Smit, MD, PhD; Jean-Charles Fruchart, PhD; John J.P. Kastelein, MD, PhD
Abstract—Large observational studies and atherosclerosis regression trials of lipid-modifying pharmacotherapy have
established that intima-media thickness of the carotid and femoral arteries, as measured noninvasively by B-mode
ultrasound, is a valid surrogate marker for the progression of atherosclerotic disease. To exploit fully the potential of
ultrasound imaging in atherosclerosis research, standardized and strictly implemented imaging protocols should be used
in both observational studies and applied clinical research. This article describes such a protocol developed at the
Academic Medical Center of the University of Amsterdam, the Netherlands. Results are presented from a study that
estimated atherosclerosis progression from childhood into old age by measuring intima-media thickness in subjects with
familial hypercholesterolemia compared with healthy controls.(Circulation. 2004;109[suppl III]:III-33–III-38.)
Key Words: B-mode ultrasound familial hypercholesterolemia intima-media thickness surrogate markers
Distribution of ‘normal’ values of common carotid artery far wall intima–media thickness (IMT) (both scales) in a population of healthy men and women by age range; AXA Study [9]. Upper and lower limits of bars are 75th upper (P75) and 25th lower percentiles (P25) of IMT distribution within the age range indicated in the x-axis. Abnormal increased IMT are values above the 75th upper percentile in each category of age. Gariepy J, Salomon J, Denarie N, Laskri F, Megnien JL, Levenson J, Simon A. Sex and topographic differences in associations between large-artery wall thickness and coronary risk profile in a French working cohort: the AXA Study. Arterioscler Thromb Vasc Biol 1998; 4: 584–590
In the ARIC population it was observed that 0.2 mm thicker carotid IMT was associated with a 28% increase in relative risk for stroke and a 33% increase in relative risk for myocardial infarction.
Graph showing disease prevalence by carotid wall thickness quartile (age, race, and gender adjusted) in middle-aged adults. CVD indicates cardiovascular disease; MI, myocardial infarction.
Arterial Wall Thickness Is Associated With Prevalent Cardiovascular Disease in Middle-Aged Adults
Fig 2 presents the age-, race-, and gender-adjusted disease prevalence by quartile of carotid wall thickness. The prevalence of MI, angina, peripheral vascular disease, and cerebrovascular disease increased across the IMT quartiles, with the lowest disease prevalence in participants with the smallest IMT and the highest disease prevalence in participants with the largest IMT. Of interest, the association between the overall mean carotid IMT and prevalent disease was also observed at the six sites (left and right common, bifurcation, and internal carotid segments). Participants with two or more prevalent diseases had a greater IMT than those with only one reported prevalent disease
The Atherosclerosis Risk in Communities (ARIC) Study
Gregory L. Burke, MD, MS; Gregory W. Evans, MS; Ward A. Riley, PhD; A. Richey Sharrett, MD; George Howard, DrPH; Ralph W. Barnes, PhD; Wayne Rosamond, PhD; Richard S. Crow, MD; Pentti M. Rautaharju, MD; Gerardo Heiss, MD, PhD for the ARIC Study Group Background and Purpose This study was done to assess the relationship between prevalent cardiovascular disease and arterial wall thickness in middle-aged US adults.
Methods The association of preexisting coronary heart disease, cerebrovascular disease, and peripheral vascular disease with carotid and popliteal intimal-medial thickness (IMT) (measured by B-mode ultrasound) was assessed in 13 870 black and white men and women, aged 45 to 64, during the Atherosclerosis Risk in Communities (ARIC) Study baseline examination (1987 through 1989). Prevalent disease was determined according to both participant self-report and measurements at the baseline examination (including electrocardiogram, fasting blood glucose, and medication use).
Results Across four race and gender strata, mean carotid far wall IMT was consistently greater in participants with prevalent clinical cardiovascular disease than in disease-free subjects. Similarly, the prevalence of cardiovascular disease was consistently greater in participants with progressively thicker IMT. The greatest differences in carotid IMT associated with prevalent disease were observed for reported symptomatic peripheral vascular disease (0.09 to 0.22 mm greater IMT in the four race-gender groups).
Conclusions These data document the substantially greater arterial wall thickness observed in middle-aged adults with prevalent cardiovascular disease. Both carotid and popliteal arterial IMT were related to clinically manifest cardiovascular disease affecting distant vascular beds, such as the cerebral, peripheral, and coronary artery vascular bed
Figure 2. Box plot of the relation between average IMT of the CCAs and the number of major coronary arteries with 70% stenosis, showing a highly significant relation but with considerable overlap of IMT values. Boxes represent the interquartile range with the mean indicated by the vertical lines, and the error bars indicate the range containing 95% of the values.
Adams MR, Nakagomi A, Keech A et al. Carotid intimamedia
thickness is only weakly correlated with the extent and
severity of coronary artery disease. Circulation 95; 92: 2127–34.
IMT is a double-line pattern visualized by echotomography on both walls of the common carotid arteries in a longitudinal image. It is formed by two parallel lines, which consist of the leading edges of two anatomical boundaries: the lumen-intima and media-adventitia interfaces. (2) Plaque is a focal structure encroaching into the arterial lumen of at least 0.5 mm or 50% of the surrounding IMT value or demonstrates a thickness of 1.5 mm as measured from the media-adventitia interface to the intima-lumen interface. These definitions will allow classification of the great majority of the carotid lesions observed with ultrasound (Mannheim consensus).
Abbreviations: KIHD=Kuopio Ischaemic Heart Disease Risk Factor Study, ARIC=Atherosclerosis Risk in Communities, CHS=Cardiovascular Health Study.
DM=diabetes mellitus, na=not available, MI=myocardial infarction, C=Caucasian A-A=African-American, RR=relative risk, HRR=hazard rate ratio,
OR=odds ratio, SD=standard deviation
*Results of Cox regression with CVD risk factors not reported, but results said to still be significant.
**Adjusted for CVD risk factors
Relation of carotid intima–media thickness (IMT) with cardiovascular events in asymptomatic subjects KIHD, Kuopio Ischaemic Heart Disease; ARIC, Atherosclerosis Risk In Communities; CHS, Cardiovascular Health Study; CCA, common carotid artery; AMI, acute myocardial infarction; CHD, coronary heart disease. *Adjusted for age and race; †adjusted for age and sex. From: Simon: J Hypertens, Volume 20(2).February 2002.159-169
94. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 1991; 11: 1245–1249. [Context Link]
95. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, Clegg LX. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987–1993. Am J Epidemiol 1997; 146: 483–494. [Context Link]
96. Chambless LE, Folsom AR, Clegg LX, Sharrett AR, Shahar E, Nieto FJ. et al. Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 2000; 151: 478–487. [Context Link]
97. O&apos;Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. New Engl J Med 1999; 340: 14–22. [Context Link]
98. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997; 96: 1432–1437
KIHDS provided pertinent data on the relative
risk increase of acute myocardial infarction associated
with carotid stenosis, plaques and IMTg.
These RR were, respectively, 6.3 (CI: 3.1/12.6),
4.2 (CI: 1.9/5.9) and 2.1 (CI: 1.1/4.1). These
results remained significant after adjustment for
major coronary risk factors. For each 0.1 mm of
CCA IMTs, the risk of AMI increased by 5.6%
Hazard ratios (HR) for MI for combinations of measures of atherosclerosis.
mod indicates moderate. AAI reflects lower-extremity atherosclerosis.
Analyses were adjusted for age and gender. Figure 2 clearly shows that for combinations of
measures of atherosclerosis, categorization according to an
extra measure of atherosclerosis adds prognostic information
with regard to the occurrence of MI to categorization according
to a single atherosclerosis measure.
Predictive Value of Noninvasive Measures of Atherosclerosis
for Incident Myocardial Infarction
The Rotterdam Study
Irene M. van der Meer, MD, PhD; Michiel L. Bots, MD, PhD;
Albert Hofman, MD, PhD; Antonio Iglesias del Sol, MD, PhD;
Deirdre A.M. van der Kuip, MD, PhD; Jacqueline C.M. Witteman, PhD
Background—Several noninvasive methods are available to investigate the severity of extracoronary atherosclerotic
disease. No population-based study has yet examined whether differences exist between these measures with regard to
their predictive value for myocardial infarction (MI) or whether a given measure of atherosclerosis has predictive value
independently of the other measures.
Methods and Results—At the baseline (1990 –1993) examination of the Rotterdam Study, a population-based cohort study
among subjects age 55 years, carotid plaques and intima-media thickness (IMT) were measured by ultrasound,
abdominal aortic atherosclerosis by x-ray, and lower-extremity atherosclerosis by computation of the ankle-arm index.
In the present study, 6389 subjects were included; 258 cases of incident MI occurred before January 1, 2000. All 4
measures of atherosclerosis were good predictors of MI independently of traditional cardiovascular risk factors. Hazard
ratios were equally high for carotid plaques (1.83 [1.27 to 2.62], severe versus no atherosclerosis), carotid IMT (1.95
[1.19 to 3.19]), and aortic atherosclerosis (1.94 [1.30 to 2.90]) and slightly lower for lower-extremity atherosclerosis
(1.59 [1.05 to 2.39]), although differences were small. The hazard ratio for MI for subjects with severe atherosclerosis
according to a composite atherosclerosis score was 2.77 (1.70 to 4.52) compared with subjects with no atherosclerosis.
The predictive value of MI for a given measure of atherosclerosis was independent of the other atherosclerosis measures.
Conclusions—Noninvasive measures of extracoronary atherosclerosis are strong predictors of MI. The relatively crude
measures directly assessing plaques in the carotid artery and abdominal aorta predict MI equally well as the more
precisely measured carotid IMT. (Circulation. 2004;109:1089-1094.)
Unadjusted Cumulative Event-free Rates for the Combined End Point of Myocardial Infarction or Stroke, According to Quintile of Combined Intima–Media Thickness.
The estimated cumulative rate of the combined end point for the fifth quintile of the combined measure was over 25 percent at seven years, as compared with a cumulative rate of less than 5 percent for the first quintile.
Calculated risk profiles have been proposed
for use in identifying persons at high risk for
myocardial infarction35 and for stroke.36 However,
borderline elevation of multiple risk factors is common
in the elderly, and the association between risk
factors and cardiovascular disease may weaken in the
later years of life.37,38 Therefore, it may be difficult
for clinicians to identify older patients with subclinical
cardiovascular disease on the basis of classic risk
factors. Increased intima–media thickness, an indicator
of subclinical disease, may reflect the consequences
of past exposure to risk factors. The addition
of measurements of intima–media thickness to
cardiovascular risk equations may help identify asymptomatic
persons who would benefit from aggressive
preventive measures.
Background The combined thickness of the intima and media of the carotid artery is associated with the prevalence of cardiovascular disease. We studied the associations between the thickness of the carotid-artery intima and media and the incidence of new myocardial infarction or stroke in persons without clinical cardiovascular disease.
Methods Noninvasive measurements of the intima and media of the common and internal carotid artery were made with high-resolution ultrasonography in 5858 subjects 65 years of age or older. Cardiovascular events (new myocardial infarction or stroke) served as outcome variables in subjects without clinical cardiovascular disease (4476 subjects) over a median follow-up period of 6.2 years.
Results The incidence of cardiovascular events correlated with measurements of carotid-artery intima–media thickness. The relative risk of myocardial infarction or stroke increased with intima–media thickness (P&lt;0.001). The relative risk of myocardial infarction or stroke (adjusted for age and sex) for the quintile with the highest thickness as compared with the lowest quintile was 3.87 (95 percent confidence interval, 2.72 to 5.51). The association between cardiovascular events and intima–media thickness remained significant after adjustment for traditional risk factors, showing increasing risks for each quintile of combined intima–media thickness, from the second quintile (relative risk, 1.54; 95 percent confidence interval, 1.04 to 2.28), to the third (relative risk, 1.84; 95 percent confidence interval, 1.26 to 2.67), fourth (relative risk, 2.01; 95 percent confidence interval, 1.38 to 2.91), and fifth (relative risk, 3.15; 95 percent confidence interval, 2.19 to 4.52). The results of separate analyses of myocardial infarction and stroke paralleled those for the combined end point.
Conclusions Increases in the thickness of the intima and media of the carotid artery, as measured noninvasively by ultrasonography, are directly associated with an increased risk of myocardial infarction and stroke in older adults without a history of cardiovascular disease
Unadjusted Incidence of Myocardial Infarction or Stroke According to Quintile of Carotid-Artery Intima–Media Thickness.
The yearly incidence of the combined end point of myocardial infarction or stroke increased with increasing quintiles of each of the measures of intima–media thickness (IMT). The rates were similar for quintiles of common-carotid-artery (CCA) intima–media thickness and internal-carotid-artery (ICA) intima–media thickness, but the gradient of increasing risk was slightly less pronounced than for the combined measure.
Background The combined thickness of the intima and media of the carotid artery is associated with the prevalence of cardiovascular disease. We studied the associations between the thickness of the carotid-artery intima and media and the incidence of new myocardial infarction or stroke in persons without clinical cardiovascular disease.
Methods Noninvasive measurements of the intima and media of the common and internal carotid artery were made with high-resolution ultrasonography in 5858 subjects 65 years of age or older. Cardiovascular events (new myocardial infarction or stroke) served as outcome variables in subjects without clinical cardiovascular disease (4476 subjects) over a median follow-up period of 6.2 years.
Results The incidence of cardiovascular events correlated with measurements of carotid-artery intima–media thickness. The relative risk of myocardial infarction or stroke increased with intima–media thickness (P&lt;0.001). The relative risk of myocardial infarction or stroke (adjusted for age and sex) for the quintile with the highest thickness as compared with the lowest quintile was 3.87 (95 percent confidence interval, 2.72 to 5.51). The association between cardiovascular events and intima–media thickness remained significant after adjustment for traditional risk factors, showing increasing risks for each quintile of combined intima–media thickness, from the second quintile (relative risk, 1.54; 95 percent confidence interval, 1.04 to 2.28), to the third (relative risk, 1.84; 95 percent confidence interval, 1.26 to 2.67), fourth (relative risk, 2.01; 95 percent confidence interval, 1.38 to 2.91), and fifth (relative risk, 3.15; 95 percent confidence interval, 2.19 to 4.52). The results of separate analyses of myocardial infarction and stroke paralleled those for the combined end point.
Conclusions Increases in the thickness of the intima and media of the carotid artery, as measured noninvasively by ultrasonography, are directly associated with an increased risk of myocardial infarction and stroke in older adults without a history of cardiovascular disease
Ultrasound Morphology Classification of the Arterial Wall and Cardiovascular Events in a 6-Year Follow-up Study[Original Contribution]Belcaro, Gianni; Nicolaides, Andrew N.; Laurora, Giuseppe; Cesarone, Maria Rosaria; De Sanctis, Mariateresa; Incandela, Lucrezia; Barsotti, Antonio
Received June 22, 1995; revision accepted January 19, 1996.From the Cardiovascular Institute, Chieti University (G.B., G.L., M.R.C., M.T.D.S., L.I., A.B.), and the PAP/PEA Project Institute, San Valentino (Pescara) (G.B., G.L., M.R.C., M.T.D.S., L.I., A.B.), Italy, and Irvine Laboratory for Cardiovascular Research and Investigation, St Mary&apos;s Hospital Medical School, London, UK (G.B., A.N.N.).Reprint requests to Dr G. Belcaro, Via Vespucci 65, 65100 Pescara, Italy.Abstract
A 6-year follow-up based on an arterial morphology classification defined with an ultrasound assessment of carotid and femoral artery bifurcations was conducted on 2322 asymptomatic subjects. Four morphology classes were considered. When 2000 subjects (86% of total subjects; 1124 males, 876 females) completed a 6-year follow-up, the study was terminated. At 6 years, no cardiovascular events were observed in subjects who were in class I (80.05% of the population sample) at inclusion; there were 69 events in classes II, III, and IV (19.95% of the population; incidence, 17.3%); 59 events, including the five deaths, occurred in classes III and IV (10.85% of the population), producing an event incidence of 27.2%. The increased event rate in classes II, III, and IV was significant (log-rank test; P &lt; .05, P &lt; .025, and P &lt; .025, respectively). Thus, the arterial morphology classification identified 19.95% of the population (subjects in classes II, III, and IV) in which all events occurred. There was a higher (P &lt; .05) rate of progression of altered arterial morphology in 6 years in classes III (26.5% of subjects progressed) and IV (41.9% progressed) than in classes I and II. The total number of cigarette-years was higher (P &lt; .05) in classes II, III, and IV than in class I. In conclusion, the ultrasound-based arterial classification was useful in selecting from the population sample 80.05% of subjects (class I) who remained event-free for 6 years. All events occurred in class II, III, and IV subjects (19.95%), and all five deaths (0.25% of the population) occurred in classes III and IV (10.85% of the sample). (Arterioscler Thromb Vasc Biol. 1996;16:851-856.)
Table 1. Ultrasound Arterial Morphology Classification
Class
Ultrasound Morphology
Score*
I
Normal: Three ultrasonic layers (intima-media, adventitia, and periadventitia) clearly separated. No disruption of lumen-intima interface for at least 3.0 cm, and/or initial alterations (lumen-intima interface disruption at intervals of &lt;0.5 cm).
2
II
Intima-media granulation: Granular echogenicity of deep, normally unechoic intimal-medial layer and/or increased intima-media thickness (&gt;1 mm).
4
III
Plaque without hemodynamic disturbance: Localized wall thickening and increased density involving all ultrasonic layers. Intima-media thickness &gt;2 mm.
6
IV
Stenotic plaque: As in III, but with hemodynamic stenosis on duplex scanning (sample volume in the center of the lumen), indicating stenosis &gt;50%.8
The score is relative to one artery. The patient&apos;s score is the sum of the scores of all four arteries
Hemodynamic disturbance is defined as moderate spectral broadening (downstroke of systole); systolic window present; diastolic window reduced and/or absent. Ratio a-b/a&lt;0.5, where a is the peak systolic velocity and b, the first peak end-systolic velocity
Table 1. Ultrasound Arterial Morphology Classification
Class
Ultrasound Morphology
Score*
I
Normal: Three ultrasonic layers (intima-media, adventitia, and periadventitia) clearly separated. No disruption of lumen-intima interface for at least 3.0 cm, and/or initial alterations (lumen-intima interface disruption at intervals of &lt;0.5 cm).
2
II
Intima-media granulation: Granular echogenicity of deep, normally unechoic intimal-medial layer and/or increased intima-media thickness (&gt;1 mm).
4
III
Plaque without hemodynamic disturbance: Localized wall thickening and increased density involving all ultrasonic layers. Intima-media thickness &gt;2 mm.
6
IV
Stenotic plaque: As in III, but with hemodynamic stenosis on duplex scanning (sample volume in the center of the lumen), indicating stenosis &gt;50%.8
The score is relative to one artery. The patient&apos;s score is the sum of the scores of all four arteries
Hemodynamic disturbance is defined as moderate spectral broadening (downstroke of systole); systolic window present; diastolic window reduced and/or absent. Ratio a-b/a&lt;0.5, where a is the peak systolic velocity and b, the first peak end-systolic velocity
myocardial infarction (a), or without revascularization (b)
in relation to mean intima-media thickness (IMT) of the
carotid artery divided into tertiles. ——=Carotid artery
IMT &lt;0·81 mm, · · ·=IMT of 0·81–1·02 mm, – – –=IMT
&gt;1·02 mm. Cox analyses showed no significant prediction
for this variable.
Kaplan–Meier curves for the likelihood of remaining without cardiovascular death or non-fatal myocardial
infarction (a), or without revascularization (b) in relation to presence (——) or absence (· · ·) of plaques
in either the carotid or femoral arteries. P&lt;0·005 for (a) and &lt;0·001 for (b).
Prognostic implications of intima-media thickness
and plaques in the carotid and femoral arteries in
patients with stable angina pectoris
C. Held1, P. Hjemdahl2, S. V. Eriksson1, I. Bjo¨ rkander1, L. Forslund3 and
N. Rehnqvist4
1Department of Medicine, Danderyd Hospital, 2Departments of Laboratory Medicine, Division of Clinical
Pharmacology, Karolinska Hospital, 3Department of Medicine, Trelleborg Hospital, Trelleborg and 4National
Board of Health and Welfare, Stockholm, Sweden
Background Ultrasonographic assessments of intimamedia
thickness and plaques in the carotid artery are widely
used as surrogate markers for coronary atherosclerosis, but
prospective evaluations are scarce and appear to be lacking
in patients with coronary artery disease. Ultrasonographic
evaluations of femoral vascular changes have not been
studied prospectively.
Methods and Results In the Angina Prognosis Study
in Stockholm (APSIS), 809 patients with stable angina
pectoris were studied prospectively during double-blind
treatment with verapamil or metoprolol. Ultrasonographic
assessments of intima-media thickness, lumen diameter and
plaques in the carotid and femoral arteries were evaluated
in a subgroup of 558 patients (182 females) with a mean age
of 607 years, and related to the risk of cardiovascular
death (n=18) or non-fatal myocardial infarction (n=26), or
revascularization (n=70) during follow-up (median 3·0
years). Univariate Cox regression analyses showed that
carotid intima-media thickness and plaques were related to
the risk of cardiovascular death or myocardial infarction.
Femoral intima-media thickness was related to cardiovascular
death or myocardial infarction, as well as to
revascularization, whereas femoral plaques were only
related to the latter. After adjustment for age, sex, smoking,
previous cardiovascular disease and lipid status, carotid
intima-media thickness failed to predict any cardiovascular
event, whereas carotid plaques tended (P=0·056) to predict
the risk of cardiovascular death or myocardial infarction.
Femoral intima-media thickness (P&lt;0·01) and plaques
(P&lt;0·05) were also related to the risk of revascularization
after adjustments.
Conclusions Carotid and femoral vascular changes
were differently related to cardiovascular events. Carotid
intima-media thickness was a weak predictor of events,
whereas femoral intima-media thickness predicted revascularization.
Plaques in the carotid artery were related to
cardiovascular death or non-fatal myocardial infarction,
whereas plaques in the femoral artery were related to
revascularization. Evaluations of plaques provided better
prediction than assessments of intima-media thickness in
patients with stable angina.
(Eur Heart J 2001; 22: 62–72, doi:10.1053/euhj.1999.2006)
Measurement of carotid arterial intima-media thickness progression, the result of each individual person&apos;s response to his or her own risk factor burden, removes inferences about the atherosclerotic process derived from traditional risk factor assessment by providing direct information about the progression of atherosclerosis at the level of the arterial wall. A screening strategy based on the rate of intima-media thickness progression is a more rational approach to prevention of coronary artery disease [2] that may improve our ability to decide who should receive antiatherosclerotic therapy to reduce risk for development of clinical symptoms. As we have shown, each carotid arterial intima-media thickness measure contributed significantly to the prediction of coronary events beyond that predicted by HDL cholesterol alone (Table 4, models 5 and 6). To the extent that common carotid arterial intima-media thickness progression is associated with risk for coronary events, a potentially enormous clinical significance is linked to the noninvasive assessment of the progression of early preintrusive atherosclerosis
The Role of Carotid Arterial Intima-Media Thickness in Predicting Clinical Coronary Events
Howard N. Hodis, MD; Wendy J. Mack, PhD; Laurie LaBree, MS; Robert H. Selzer, MS; Chao-ran Liu, MD; Ci-hua Liu, MD; and Stanley P. Azen, PhD
15 February 1998 | Volume 128 Issue 4 | Pages 262-269
Background: Carotid arterial intima-media thickness is used as a noninvasive surrogate end point to measure progression of atherosclerosis, but its relation to coronary events has not been fully explored.
Objective: To determine whether carotid arterial intima-media thickness predicts coronary events.
Design: Long-term follow-up (average, 8.8 years) of a previously assembled cohort of persons who completed the 2-year Cholesterol Lowering Atherosclerosis Study, a randomized arterial imaging trial designed to study the effects of lipid lowering on progression of atherosclerosis.
Setting: University-based ultrasonography laboratory.
Patients: 146 men 40 to 59 years of age who had previously had coronary artery bypass graft surgery.
Measurements: Preintrusive atherosclerosis in the common carotid artery was evaluated every 6 months with B-mode ultrasonography, and intrusive atherosclerosis in the coronary arteries was evaluated at baseline and at 2 years with quantitative coronary angiography. After the trial, the incidences of coronary events (nonfatal acute myocardial infarction, coronary death, and coronary artery revascularization) were documented.
Results: For each 0.03-mm increase per year in carotid arterial intima-media thickness, the relative risk for non-fatal myocardial infarction or coronary death was 2.2 (95% CI, 1.4 to 3.6) and the relative risk for any coronary event was 3.1 (CI, 2.1 to 4.5) (P &lt; 0.001). Absolute intima-media thickness was also related to risk for clinical coronary events (P &lt; 0.02). Absolute thickness and progression in thickness predicted risk for coronary events beyond that predicted by coronary arterial measures of atherosclerosis and lipid measurements (P &lt; 0.001).
Conclusion: Noninvasive B-mode ultrasonographic measurement of progression of intima-media thickness in the distal common carotid artery is a useful surrogate end point for clinical coronary events.
Carotid Intima-Media Thickness, Plaques, and Framingham
Risk Score as Independent Determinants of Stroke Risk
Pierre-Jean Touboul, MD; Julien Labreuche, BS; Eric Vicaut, MD, PhD; Pierre Amarenco, MD; on
behalf of the GENIC Investigators*
Background and Purpose—The Framingham stroke risk score (FSRS) and Framingham cardiovascular risk score (FCRS)
estimate the individual absolute cardiovascular and stroke risks. Common carotid artery intima-media thickness
(CCA-IMT) and carotid plaques (CPs) are markers of subclinical atherosclerosis and help in the early identification of
presymptomatic individuals. The purpose of this study was to correlate Framingham risk score (FRS) with CCA-IMT
and CPs and evaluate their respective contribution to stroke risk.
Methods—In 510 consecutive patients with brain infarction and 510 matched controls, we calculated the FSRS and FCRS
for each individual and performed carotid ultrasonography. Mean CCA-IMT was measured off-line at a central core
laboratory, and presence of CPs was assessed.
Results—FRS progressively increased according to tertiles of CCA-IMT (P for trend 0.0001). The part of the variances
of FSRS and FCRS explained by CCA-IMT was respectively 11% and 20%. The relationships between CCA-IMT and
FRS were significantly different between patients with or without CPs (P for interaction 0.005). With increasing
CCA-IMT, the 10-year FRS gradually increased between 10% and 20% in the presence of CPs and between 5% and
20% in the absence of CPs. Multiple conditional logistic regression for matched sets showed that CCA-IMT, FCRS, and
CPs were independently associated with stroke risk, with an odds ratio of 1.68 (1.25 to 2.26; P0.0006), 2.16 (1.57 to
2.98; P0.0001), and 2.73 (1.68 to 4.44; P0.0001), respectively, meaning that each of them may be important for
evaluation of the individual cardiovascular risk.
Conclusions—CCA-IMT, CPs, and FRSs correlated well. The CCA-IMT value may help discriminate between subjects
at low or high 10-year risk. (Stroke. 2005;36:1741-1745.)
Figure 1. Meta-analysis of Mortality Associated with Abdominal Aortic Aneurysms in the Abdominal Aortic Aneurysm Screening Trials (Text Description)
Figure 1 examines the impact of an invitation to attend screening on AAA-related mortality for men by pooling trial results using meta-analysis. Forest plots show that all trials had odds ratios (ORs) favoring an association between an invitation to attend screening and a reduction in AAA-related deaths. The association was significant in the Multicentre Aneurysm Screening Study (MASS) (OR, 0.58 [95% CI, 0.42-0.78]) and in the Viborg County study (OR, 0.31 [95% CI, 0.13-0.79]). In the Chichester trial, the OR was 0.59 (95% CI, 0.27-1.29). In the Western Australia trial, the OR was 0.72 (95% CI, 0.39-1.32).
The pooled OR showed a reduction in AAA-related mortality favoring screening (OR, 0.57 [95% CI, 0.45-0.74]). MASS, the largest of the trials and the trial with the narrowest CI, contributed the most weight (65.9%) to the pooled OR. The Viborg County study contributed 7.3 percent, the Chichester trial contributed 10.0 percent, and the Western Australia trial contributed 16.8 percent. In sensitivity analyses, removing any of the other 3 studies, separately or in combination, had very little impact on the pooled OR and CI. When MASS was removed from the meta-analysis, however, the pooled meta-analysis based on the other 3 studies still showed a significant reduction in AAA-related mortality (OR, 0.56 [95% CI, 0.36-0.88]).
Schematic drawing of the vasa vasorum and associated neovascularization of the atherosclerotic plaque revealing the
“outside-in” growth of angiogenesis.
Ultimately, these new findings may have significant
clinical ramifications. Occlusive cardiovascular
disease appears to correlate with the presence and
degree of neovascularization within the vasa vasorum
and plaque.51 Moreover, these contrast-enhanced
c-IMT observations may call into question the traditional
belief that atherosclerotic plaque emanates from
the lumen, suggesting instead that plaque neovascularization
arises from the vasa vasorum (adventitial
vessels)—“outside-in” as opposed to “inside-out.”
Am J Cardiol 2004;93(suppl):32C–48C
Despite dramatic advances over the past decade, the field of atherosclerosis imaging for cardiovascular risk assessment is in its infancy. Further data are needed to confidently and accurately establish an independent role in cardiovascular risk prediction over global risk assessments and with consideration of newer serologic risk markers such as C-reactive protein. The comparative performance of different imaging modalities must be determined. These studies will establish benchmarks for comparison with newer imaging modalities, such as plaque bioactivity imaging tests,[18 and 19] as they emerge. The data generated on atherosclerosis imaging must be broadly generalizable and incorporate important demographic subgroups including women and ethnic minorities in whom the relationships between atherosclerosis imaging targets and outcomes may vary. [20] Lastly, although more commonly applied to medical therapies, it is necessary to demonstrate through formal technology assessments that atherosclerosis imaging techniques favorably impact cardiovascular outcomes in a cost-effective manner. This goal will clearly be a partnership between tests, patients, and providers, and require accurate modalities that are appropriately clinically utilized and lead to effective risk reduction therapies that are fully used and complied with.
Variance (mm2/y2) of a randomly selected estimated progression rate for outcome measures based on all segments, and the relative contributions of readers, nonsystematic error (noise), and intersubject differences to this variance, for several study design options: annual single or duplicate examination for 2, 3, 6, and 8 years of follow-up.
Distribution of IMT in IMT studies in Adults
Atherosclerotic Changes of
Extracoronary Arteries Are
Associated With the Extent of
Coronary Atherosclerosis
John P. Lekakis, MD, Christos M. Papamichael, MD, Adriana T. Cimponeriu, MD,
Kimon S. Stamatelopoulos, MD, Theodoros G. Papaioannou, PhD, John Kanakakis, MD,
Maria K. Alevizaki, MD, Aggeliki Papapanagiotou, MD, Anastasios Th. Kalofoutis, MD,
and Stamatios F. Stamatelopoulos, MD
The aim of the present study was to examine the association
between carotid and femoral artery intima media
thickness (IMT) and the extent and severity of coronary
artery disease (CAD) as well as the effects of
traditional vascular risk factors on the atherosclerotic
changes in the carotid and femoral arteries. Two hundred
twenty-four patients who underwent coronary angiography
for suspected CAD were evaluated by Bmode
ultrasound imaging of the common carotid,
internal carotid, carotid bifurcation, and femoral artery
for measurement of IMT; traditional vascular risk factors
were also evaluated in these patients. CAD extent was
evaluated by the number of diseased vessels and by
Gensini score. Age, male gender, and diabetes were
common risk factors for higher CAD extent and higher
carotid and femoral IMT. Insulin levels were correlated
with femoral IMT and CAD extent, whereas blood lipids
were correlated predominantly with carotid IMT. IMT
from carotid and femoral arteries increased significantly
with an increase in CAD extent. Using multiple stepwise
regression analysis, the following parameters were
found to be independent predictors of CAD extent: male
gender (p &lt;0.0001), common femoral artery IMT (p 5
0.0028), common carotid artery IMT (p 5 0.015), age
(p 5 0.02), diabetes mellitus (p 5 0.035), and carotid
artery bulb IMT (p 5 0.04). Common femoral IMT was
the only independent parameter for predicting Gensini
score (p &lt;0.0001). In conclusion, there are territorial
differences in the various arterial beds regarding their
response to risk factors. Femoral artery and carotid bulb
are independent predictors of CAD extent and the inclusion
of these measurements would add information to
that provided by the common carotid artery. Q2000
by Excerpta Medica, Inc.
(Am J Cardiol 2000;85:949–952)
A comparison of 95% Cls for the annualized progression rate of an individual from 3, 4, 6, and 8 years of follow-up versus the estimated distribution of ``true&apos;&apos; progression rates for the ACAPS cohort. The horizontal axis is centered at the mean annual progression rate for the ACAPS control cohort and includes tick marks +/- 2 SD along the estimated distribution. IMT is averaged across all segments; a single reader is assumed, and no adjustment for missing data is implemented.
Differential Association of Common Carotid Intima-Media
Thickness and Carotid Atherosclerotic Plaques With
Parental History of Premature Death From
Coronary Heart Disease
The EVA Study
Mahmoud Zureik, Pierre-Jean Touboul, Claire Bonithon-Kopp, Dominique Courbon,
Isabelle Ruelland, Pierre Ducimetie`re
Abstract—Familial aggregation of coronary heart disease (CHD) has been reported in several studies. The specific
underlying mechanisms and the relative contribution of atherosclerosis to the subsequent CHD events in subjects with
family history are not well established. This study examined the association of parental history of premature death from
CHD with ultrasound carotid measurements of atherosclerosis in a population of 1040 subjects aged 59 to 71 years.
Ultrasound examination included measurements of intima-media thickness at the common carotid arteries (at sites free
of plaques) and assessment of atherosclerotic plaques in the extracranial carotid arteries. Subjects who reported that 1
or both parents had sudden death or died of myocardial infarction before the age of 65 years were considered positive
for parental history of premature death from CHD (n553, 5.1%). The prevalence of atheromatous plaques was higher
in subjects with history of premature death from CHD compared with those without history (41.5% versus 20.5%,
P,0.001). Age- and sex-adjusted odds ratio of atheromatous plaques associated with parental history of premature death
from CHD was 2.85 (95% confidence interval, 1.60 to 5.08; P,0.001). Multivariate adjustment for major known
cardiovascular risk factors did not markedly alter the results (odds ratio, 2.70; P,0.002). In contrast, common carotid
intima-media thickness was not associated with parental history of premature death from CHD (0.6660.11 versus
0.6660.12 mm, P50.76). These findings were observed in both men and women. In conclusion, parental history of
premature death from CHD is strongly associated with carotid plaques. Familial transmission of CHD risk does not seem
to be specifically mediated by arterial wall thickening measured at sites free of plaques. (Arterioscler Thromb Vasc
Biol. 1999;19:366-371.)
Heart 2005;91;819-820
Celegon
R Komorovsky, A Desideri, S Coscarelli, L Cortigiani, D Tonello, A Visonà and L
Prognostic significance of characteristics of carotid plaques in patients with acute coronary syndromes
IMT indicates intima-media thickness.
1 Cutpoints used were the 40th, 60th, and 80th percentiles of the IMT distribution.
2 Model I adjusted for age and sex; Model II adjusted for age, sex, previous myocardial infarction, and previous stroke; and Model III adjusted for age, sex, previous myocardial infarction or stroke, body mass index, smoking, systolic blood pressure, hypertension, total cholesterol, HDL cholesterol, and diabetes mellitus.
3 Subjects with a history of myocardial infarction or stroke were excluded
Background Noninvasive assessment of intima-media thickness (IMT) is widely used in observational studies and trials as an intermediate or proxy end point for cardiovascular disease. However, data showing that IMT predicts cardiovascular disease are limited. We studied whether common carotid IMT is related to future stroke and myocardial infarction.
Methods and Results We used a nested case-control approach among 7983 subjects aged 55 years participating in the Rotterdam Study. At baseline (March 1990 through July 1993), ultrasound images of the common carotid artery were stored on videotape. Determination of incident myocardial infarction and stroke was predominantly based on hospital discharge records. Analysis (logistic regression) was based on 98 myocardial infarctions and 95 strokes that were registered before December 31, 1994. IMT was measured from videotape for all case subjects and a sample of 1373 subjects who remained free from myocardial infarction and stroke during follow-up. The mean duration of follow-up was 2.7 years. Results were adjusted for age and sex. Stroke risk increased gradually with increasing IMT. The odds ratio for stroke per standard deviation increase (0.163 mm) was 1.41 (95% CI, 1.25 to 1.82). For myocardial infarction, an odds ratio of 1.43 (95% CI, 1.16 to 1.78) was found. When subjects with a previous myocardial infarction or stroke were excluded, odds ratios were 1.57 (95% CI, 1.27 to 1.94) for stroke and 1.51 (95% CI, 1.18 to 1.92) for myocardial infarction. Additional adjustment for several cardiovascular risk factors attenuated these associations: 1.34 (95% CI, 1.08 to 1.67) and 1.25 (95% CI, 0.98 to 1.58), respectively.
Conclusions The present study, based on a short follow-up period, provides evidence that an increased common carotid IMT is associated with future cerebrovascular and cardiovascular events.
umerous biomarkers may have clinical utility for predicting relative risk of future cardiovascular events. In available population-based studies, however, the relative magnitude of these biomarkers for predicting risk has been small in direct comparison to C-reactive protein (CRP). Citation:Reprinted with permission from Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363-9. www.lww.com Source
SourceCardiosource image provided by the American College of Cardiology Foundation
On the basis of our systematic review and meta-analyses, an invitation to attend AAA screening may reduce AAA-related mortality by 43% in men age 65 to 75 years. The Western Australia screening study also included patients 75 to 83 years of age. In a post hoc analysis, a significant reduction of AAA-related mortality from screening was seen in men 65 to 74 years of age but not in older men. The absolute risk reduction for AAA-related deaths over 4 to 5 years ranged from 3.6 per 10 000 in the Western Australia trial to 21 per 10,000 in the Chichester and Viborg County trials. It is important to note that these estimates pertain to screening in populations and not to screening for individuals. An invitation to screening did not appear to reduce all-cause mortality. This result is not unexpected, since AAA-related mortality accounts for only a small proportion of all deaths in older men. In MASS, for example, AAA-related mortality, including operative mortality for elective and emergency surgical repair, was the attributed cause of death in 2% of those invited to screening versus 3% of controls. As is true in screening for other diseases, the influence of competing causes of death makes it difficult to detect changes in all-cause mortality; to do so, substantially larger trials would be required.48
Only the Chichester trial included women and showed no significant benefit of screening in reducing AAA-related mortality. An adequately powered trial of population-based screening for AAA, while desirable, would be challenging to perform. Abdominal aortic aneurysms are much less prevalent in women overall, occur on average 10 years later than in men, and are most likely to rupture after 80 years of age.9 While screening has been recommended for women older than 65 years of age with cardiac risk factors49, we found no controlled studies that support this recommendation.
After adjustment for other risk factors, a history of smoking is associated with a 5-fold increase in AAA risk.1 Using a model of AAA screening in 65- to 74-year-old men, we estimated that 89% of AAA-related deaths prevented would be attributable to screening in 69% of those men with any history of smoking during their lifetime. Neither a current history of smoking nor consideration of other AAA risk factors appears to be more accurate than age, sex, and lifetime smoking history in selecting a high-risk screening population.
After at least 10 years of followup, periodic ultrasonography in men who had normal ultrasonography results at age 65 years found that the incidence of new AAAs was low. When AAAs were found, they were less than 4.0 cm and therefore were not likely to present a significant risk for rupture. On the basis of these findings, it appears unlikely that repeated screening of asymptomatic average-risk men older than age 65 years would be beneficial.
No significant physical harms were associated with ultrasonography screening. Changes in self-reported psychological and general health perception in those found to have AAA and those with normal results on ultrasonography were generally mild and did not persist over time. Our review of harms indicates that elective AAA repair may result in significant mortality and morbidity. The risk for death and complications increased with age and preoperative comorbid conditions. More favorable outcomes were seen when experienced vascular surgeons in high-volume hospitals performed the surgery.
Several limitations should be considered when interpreting our results. Because of the potential for misclassification of the cause of death from death certificates, the results of screening trials may be biased in favor of screening if deaths from disease, treatment, or screening among those screened are falsely attributed to other causes, that is, the so-called &quot;slippery linkage&quot; bias.50 Data on causes of death from MASS argue against this; deaths from ischemic heart disease decreased slightly in those invited to screening compared with uninvited controls, while cancer-related deaths, which would not be attributable to AAA screening or treatment, increased slightly.
Potential confounding of screening trial results may also have occurred because of improved management of cardiovascular risk factors in those invited to screening. In MASS, for example, those attending screening may have benefited from improved treatment of hypertension because blood pressure was measured at the screening visit and was reported to the general practitioner.34 Hypertension treatment, however, is more effective in reducing stroke risk than in reducing coronary artery disease risk.51 In MASS, the percentage of deaths from ischemic heart disease was slightly lower in those invited to screening, but the percentage of deaths from strokes was the same in both groups, suggesting that improved hypertension treatment did not influence trial outcomes.
There were important differences in the design of the 4 population screening trials. The outcomes of the Viborg County study, in particular, were ascertained by using only hospital records, so an unknown number of AAA-related outcomes deaths occurring out of the hospital would have been missed. In the Western Australia study, patients found to have AAAs at screening were referred to their primary physicians for subsequent evaluation and management. In MASS and in the Viborg County and Chichester trials, followup scanning was performed periodically by study personnel. These factors had little impact on the meta-analysis of AAA-related mortality, however, because the pooled effect size was primarily determined by the MASS results.
Since all 4 AAA screening trials were conducted outside the United States and no data were provided on the race and ethnicity of the participants, the extent to which these findings can be generalized to the U.S. population is not clear. At this time, it is unlikely that a population-based trial would be performed in the United States, particularly given the strength of the evidence favoring screening in the trials reviewed here. We believe that these studies provide the best evidence available to support recommendations for AAA screening in the United States.
Finally, as previously noted, estimates of absolute risk reduction from the 4 trials are based on screening for AAA in populations and do not apply to screening of particular individuals. These population-based estimates incorporate variability in factors such as rate of participation in screening, accuracy and reliability of ultrasonography, selection factors in those who did and did not attend screening, and rates of operative mortality and complications. In shared decision making, estimating a patient&apos;s absolute risk for AAA depends on a variety of factors, such as age, sex, smoking history, family history, and cardiovascular risk factors, as well as the patient&apos;s willingness to accept the potential harms of screening and treatment if an AAA is found.
On the basis of our review, we conclude that population screening for AAA in men age 65 to 74 years appears to reduce deaths from AAA. Treatment is associated with significant risks for operative death and complications. These risks, however, may be acceptable to men with AAAs greater than 5.5 cm, which are most prone to rupture.
Common carotid artery, carotid bifurcation (bulb) and external and internal carotid arteries of a healthy 50 year old male showing normal carotid intima-media thickness (A) and common carotid artery and carotid bifurcation of a 55 year old African American female showing diffuse thickening of intimal-medial layer along the near (near the skin) and far wall (furthest from skin) of common carotid artery and carotid bifurcation. CCA=common carotid artery, ECA=external carotid artery, ICA=internal carotid artery.
Effect of lipid-lowering drugs on carotid intima–media thickness (IMT) in randomized double-blind trials Data are mean ± SE. CCA, Common carotid artery; CA, carotid; FE, femoral; NS, non significant. *Estimated from change in IMT after 2 years. From: Simon: J Hypertens, Volume 20(2).February 2002.159-169
100. Salonen R, Nyyssonen K, Porkkala E, Rummukainen J, Belder R, Park JS, Salonen JT. Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation 1995; 92: 1758–1764. [Context Link]
101. Mercuri M, Bond MG, Sirtori CR, Veglia F, Crepaldi G, Feruglio FS. et al. Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic Mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study. Am J Med 1996; 101: 627–634. [Context Link]
102. Crouse III JR, Byington RP, Bond G, Espeland MA, Craven TE, Sprinkle JW. et al. Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC II). Am J Cardiol 1995; 75: 455–459. [Context Link]
103. de Groot E, Jukema JW, Montauban van Swijndregt AD, Zwinderman AH, Ackerstaff RG, van der Steen AF. et al. B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS). J Am Coll Cardiol 1998; 31: 1561–1567. [Context Link]
104. Furberg CD, Adams HP Jr, Applegate WB, Byington RP, Espeland MA, Hartwell T. et al. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Circulation 1994; 90: 1679–1687. [Context Link]
105. Smilde TJ, Wissen SV, Wollersheim H, Trip MD, Kastelein JJP, Stalenhoef AFH. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomized double blind trial Lancet 2001; 357: 577–581
110. Blankenhorn DH, Selzer RH, Crawford DW, Barth JD, Liu CR, Liu CH. et al. Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound. Circulation 1993; 88: 20–28. [Context Link]
111. Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu C, Liu C. et al. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial. Ann Intern Med 1996; 124: 548–556. [Context Link]
112. MacMahon S, Sharpe N, Gamble G, Hart H, Scott J, Simes J, White H. Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group. Circulation 1998; 97: 1784–1790. [Context Link]
Common carotid artery, carotid bifurcation (bulb) and external and internal carotid arteries of a healthy 50 year old male showing normal carotid intima-media thickness (A) and common carotid artery and carotid bifurcation of a 55 year old African American female showing diffuse thickening of intimal-medial layer along the near (near the skin) and far wall (furthest from skin) of common carotid artery and carotid bifurcation. CCA=common carotid artery, ECA=external carotid artery, ICA=internal carotid artery.
The British Regional Heart Study Ebrahim et al 1999, stroke
Carotid Plaque, Intima Media Thickness, Cardiovascular
Risk Factors, and Prevalent Cardiovascular Disease in
Men and Women
The British Regional Heart Study
Shah Ebrahim, DM; Olia Papacosta, MSc; Peter Whincup, MB, PhD; Goya Wannamethee, PhD;
Mary Walker, MFPHM[Hon]; Andrew N. Nicolaides, FRCS; Surinder Dhanjil, MSc;
Maura Griffin, MSc; Gianni Belcaro, MD; Ann Rumley, PhD; Gordon D.O. Lowe, MD
Background and Purpose—B-mode ultrasound is a noninvasive method of examining the walls of peripheral arteries and
provides measures of the intima-media thickness (IMT) at various sites (common carotid artery, bifurcation, internal
carotid artery) and of plaques that may indicate early presymptomatic disease. The reported associations between
cardiovascular risk factors, clinical disease, IMT, and plaques are inconsistent. We sought to clarify these relationships
in a large, representative sample of men and women living in 2 British towns.
Methods—The study was performed during 1996 in 2 towns (Dewsbury and Maidstone) of the British Regional Heart Study that
have an &apos;2-fold difference in coronary heart disease risk. The male participants were drawn from the British Regional Heart
Study and were recruited in 1978–1980 and form part of a national cohort study of 7735 men. A random sample of women
of similar age to the men (55 to 77 years) was also selected from the age-sex register of the general practices used in the
original survey. A wide range of data on social, lifestyle, and physiological factors, cardiovascular disease symptoms, and
diagnoses was collected. Measures of right and left common carotid IMT (IMTcca) and bifurcation IMT (IMTbif) were made,
and the arteries were examined for plaques 1.5 cm above and below the flow divider.
Results—Totals of 425 men and 375 women were surveyed (mean age, 66 years; range, 56 to 77 years). The mean (SD) IMTcca
observed were 0.84 (0.21) and 0.75 (0.16) mm for men and women, respectively. The mean (SD) IMTbif were 1.69 (0.61) and
1.50 (0.77) mm for men and women, respectively. The correlation between IMTcca and IMTbif was similar in men (r50.36)
and women (r50.38). There were no differences in mean IMTcca or IMTbif between the 2 towns. Carotid plaques were very
common, affecting 57% (n5239) of men and 58% (n5211) of women. Severe carotid plaques with flow disturbance were
rare, affecting 9 men (2%) and 6 women (1.6%). Plaques increased in prevalence with age, affecting 49% men and 39% of
women aged ,60 years and 65% and 75% of men and women, respectively, aged .70 years. Plaques were most common
among men in Dewsbury (79% affected) and least common among men in Maidstone (34% affected). IMTcca showed a
different pattern of association with cardiovascular risk factors from IMTbif and was associated with age, SBP, and FEV1 but
not with social, lifestyle, or other physiological risk factors. IMTbif and carotid plaques were associated with smoking, manual
social class, and plasma fibrinogen. IMTbif and carotid plaques were associated with symptoms and diagnoses of
cardiovascular diseases. IMTbif associations with cardiovascular risk factors and prevalent cardiovascular disease appeared to
be explained by the presence of plaques in regression models and in analyses stratified by plaque status.
Conclusions—IMTcca, IMTbif, and plaque are correlated with each other but show differing patterns of association with risk factors and
prevalent disease. IMTcca is strongly associated with risk factors for stroke and with prevalent stroke, whereas IMTbif and plaque are
more directly associated with ischemic heart disease risk factors and prevalent ischemic heart disease. Our analyses suggest that
presence of plaque, rather than the thickness of IMTbif, appears to be the major criterion of high risk of disease, but confirmation of
these findings in other populations and in prospective studies is required. The association of fibrinogen with plaque appears to be
similar to its association with incident cardiovascular disease. Further work elucidating the composition of plaques using ultrasound
imaging would be helpful, and more data, analyzed to distinguish plaque from IMTbif and IMTcca, are required to understand the
significance of thicker IMT in the absence of plaque. (Stroke. 1999;30:841-850.)
Key Words: atherosclerosis n cardiovascular diseases n carotid arteries n risk factors n ultrasonography
Clin Cardiol. 2004 Jul;27(7):388-92.
Vascular age: integrating carotid intima-media thickness measurements with global coronary risk assessment.Stein JH, Fraizer MC, Aeschlimann SE, Nelson-Worel J, McBride PE, Douglas PS.BACKGROUND: An imaging test that quantifies atherosclerotic burden and that can be integrated with existing risk stratification paradigms would
be a very useful clinical tool. HYPOTHESIS: Measurement of carotid intima-media thickness (CIMT) is feasible in a clinical setting. Such measurements
can be integrated into coronary risk assessment models. METHODS: Carotid intima-media thickness was measured by B-mode ultrasound in 82 consecutive
patients without manifest atherosclerotic vascular disease. The values were used to determine &quot;vascular age&quot; (VA) based on nomograms from the Atherosclerosis
Risk in Communities study. Vascular age was substituted for chronological age and standard and vascular age-adjusted 10-year coronary heart disease (CHD) risk
estimates were compared. RESULTS: The mean chronological age was 55.8 +/- 9.0 years. The mean VA using CIMT was 65.5 +/- 18.9 years (p &lt; 0.001). The
Framingham 10-year hard CHD risk estimate was 6.5 +/- 4.9%. Substituting CIMT-derived VA for chronological age increased the 10-year CHD risk estimate
to 8.0 +/- 6.8% (p &lt; 0.001).
Of 14 subjects initially at intermediate risk, 5 (35.7%) were reclassified as higher risk and 2 (14.3%) were reclassified as lower risk.
Significant predictors of reclassification were tobacco use, high-density lipoprotein cholesterol, systolic blood pressure, and low-density lipoprotein cholesterol.
CONCLUSIONS: Measurement of CIMT, a noninvasive estimate of current atherosclerotic burden, is feasible in a clinical setting and can be integrated into CHD
risk assessment models. Determining VA using CIMT values may help individualize the age component of population-based CHD risk estimates. This strategy
should be tested in a large trial with hard clinical endpoint
he balance of pro- and anti-inflammatory mediators may determine vascular health or illness. The list of inflammatory molecules, in particular those that are pro-inflammatory, are rapidly expanding. Some of the more prominent ones are listed. ACE-I = angiotensin-converting enzyme inhibitor; ARB = angiotensin receptor blocker; CRP = C-reactive protein; IL = interleukin; MCP = monocyte chemoattractant protein; MMP = matrix metalloproteinase; NF = nuclear factor; PPAR = peroxisome proliferator-activated receptor; TNF = tumor necrosis factor. Citation:Reproduced with permission from Mills R, Bhatt DL. The yin and yang of arterial inflammation J Am Coll Cardiol 2004;44:50-52. Copyright of the American College of Cardiology Foundation. SourceCardiosource image provided by the American College of Cardiology Foundation
Prevalence of multiple risk factors in young adults with IMT in the extreme fifth percentiles: The Bogalusa Heart Study. Risk factors included hypertension, obesity, dyslipidemia, adverse glucose level, and smoking
Cardiovascular Risk Profile of Asymptomatic
Healthy Young Adults with Increased Femoral
Artery Intima-Media Thickness: The Bogalusa
Heart Study
TIMIR K. PAUL, MD, MPH; SATHANUR R. SRINIVASAN, PHD; CHEN WEI, MD, PHD;
SHENGXU LI, MD; AZAD R. BHUIYAN, MD, MPH; M. GENE BOND, PHD;
RONG TANG, MD, MS; GERALD S. BERENSON, MD
ABSTRACT: Background: Femoral artery intima-media
thickness (IMT), like carotid IMT, is a surrogate indicator
of atherosclerotic coronary and peripheral vascular diseases
in middle-aged and older adults. This study examined
the cardiovascular disease risk profile of asymptomatic
young adults with increased femoral artery IMT.
Methods: Femoral artery IMT was measured by B-mode
ultrasonography in 1080 black and white subjects (aged
24-43 years; 71% white, 43% male) enrolled in the
Bogalusa Heart Study. Individuals in the top (n 54)
versus bottom fifth (n 54) percentiles distribution of
femoral IMT were compared for traditional cardiovascular
risk factors profile. Univariate analysis compared the
two groups, t-tests and 2 tests were performed. Results:
The top and bottom fifth percentiles of IMT differed with
respect to age (P 0.001), systolic blood pressure (P
0.05), diastolic blood pressure (P 0.05), total cholesterol
(P 0.01), low-density lipoprotein (LDL) cholesterol
(P 0.001), non-high-density lipoprotein (HDL)
cholesterol (P 0.01) and smoking status (P 0.01). In
terms of prevalence of clinically defined traditional risk
factors, individuals at the top versus bottom fifth percentile
of IMT distribution had significantly higher prevalence
of high LDL cholesterol (130 mg/dL), non-HDL
cholesterol (160 mg/dL), and cigarette smoking. The
odds ratio for individuals with three or more risk factors
versus no risk factors having IMT in the top fifth percentile
was 4.7 (P 0.01). Conclusion: The observed
adverse effect of cardiovascular risk factors on IMT of
femoral artery, a surrogate measure of coronary and
peripheral atherosclerosis, in asymptomatic young individuals
underscores the need for risk factors profiling in
early life. These observations have important implications
in preventive medicine. KEY INDEXING TERMS:
Femoral artery; Intima-media thickness; Risk factors;
Ultrasonography; Peripheral vascular disease. [Am J
Med Sci 2005;330(3):105–110.]
Table 1. Estimated Costs of Common Cardiac Imaging Procedures and Other Laboratory and
Office Visit Costs Using Published and Available Data Sources
Mark and Shaw et al. JACC Vol. 41, No. 11, 2003
Task Force #5—Is Atherosclerosis Imaging Cost Effective? JACC June 4, 2003:1855–917
This technique is simple and
generally considered as reproducible, but one
important limitation lies in its inability to distinguish
the intimal from the medial layer.
In fact, this double-line pattern is made up of
successive black and white interfaces. For the far
wall of the common carotid artery, the first
interface is clear-cut corresponding to the difference
of acoustic impedance between E-mail address: pjtw@noos.fr (P.-J. Touboul). the blood and
European Journal of Ultrasound 16 (2002) 105/113
www.elsevier.com/locate/ejultrasou
0929-8266/02/$ - see front matter # 2002 Published by Elsevier Science Ireland Ltd.
PII: S 0 9 2 9 - 8 2 6 6 ( 0 2 ) 0 0 0 5 0 - 2
the first layer of the arterial wall. The second one is
blurred due to the progressive decrease of echo
intensity along the intima media complex. The
third one, also clear-cut, is a black and white
interface related to media/adventitia layers interface.
These observations have conducted to automate
the detection of the double-line pattern by
analysing the variation of density produced by this
arterial structure (Touboul et al., 1992).
M Ludwig 1994
A simple algorithm derived from results of the Atherosclerosis Risk in Communities (ARIC) Study is used to compute an estimate of absolute cardiovascular risk (percent chance of experiencing a heart attack or stroke within 10 years) from the composite mean CIMT calculation. These data are derived from the long-term follow-up of an initial population sample of 16,000 men and women between 45 years and 65 years of age (3,4). This risk estimate should be accurate to within approximately + 2.5 % per 10 years if the accuracy and reliability of the CIMT measurement is of the order of 0.10 mm. A specific CIMT-based risk cutpoint can be selected to optimize the cost effectiveness of the atherosclerosis screening program.
3. Chambless LE, Heiss G, Folsom AR, et al.: Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study. 1987-1993. Am J Epidemiol 1997, 146:483-494.
4. Chambless LE, Folsom AR, Clegg LX, et al.: Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Am J. Epidemiol 2000, 151:478-487.
KIHDS provided pertinent data on the relative
risk increase of acute myocardial infarction associated
with carotid stenosis, plaques and IMTg.
These RR were, respectively, 6.3 (CI: 3.1/12.6),
4.2 (CI: 1.9/5.9) and 2.1 (CI: 1.1/4.1). These
results remained significant after adjustment for
major coronary risk factors. For each 0.1 mm of
CCA IMTs, the risk of AMI increased by 5.6%
Force Recommend?
The U.S. Preventive Services Task Force
(USPSTF) recommends one-time
screening for abdominal aortic aneurysm
by abdominal ultrasonography for men
between the ages of 65 and 75 who have
ever smoked (ie, at least 100 cigarettes
during one&apos;s lifetime). The USPSTF
makes no recommendation for or
against screening for abdominal aortic
aneurysm in men between the ages of
65 and 75 who have never smoked. The
USPSTF recommends against routine
screening for abdominal aortic aneurysm
in women.
What Are the Risk Factors
for Abdominal Aortic
Aneurysm?
Being male, 65 or older, and ever having
smoked are the major risk factors for
abdominal aortic aneurysm. A firstdegree
family history of abdominal
aortic aneurysm requiring surgical repair
also elevates a man&apos;s risk for this
condition; this may also be true for
women but the evidence is less certain.
What Are the Potential
Benefits of Screening and
Treatment for Abdominal
Aortic Aneurysm?
Screening for abdominal aortic
aneurysm and open surgical repair of
abdominal aortic aneurysms of 5.5 cm
or more in older men leads to an
estimated 43% reduction in mortality
from abdominal aortic aneurysm. In
men with abdominal aortic aneurysms
of 4.0 to 5.4 cm, periodic surveillance,
combined with elective surgery in those
whose abdominal aortic aneurysm has
progressed, offers comparable mortality
benefit to routine elective surgery.
Currently, there is no evidence to
support any intervention in those with
small abdominal aortic aneurysms
(3.0-3.9 cm), although some expert
opinion-based recommendations favor
annual ultrasonography for these
patients.
The potential benefit of screening for
abdominal aortic aneurysm among
women aged 65 to 75 is low due to the
small number of deaths related to this
condition in this population. A clinician
may, however, choose to discuss
screening in unusual circumstances, such
as in the case of a healthy female smoker
in her early 70s who has a first-degree
What&apos;s New from the U.S. Preventive Services Task Force is a series of fact sheets based on recommendations of the
USPSTF. The USPSTF systematically reviews the evidence of effectiveness of a wide range of clinical preventive
services—including screening, counseling, and chemoprevention (the use of medication to prevent disease)—to
develop recommendations for preventive care in the primary care setting. This fact sheet presents highlights of
USPSTF recommendations on this topic and should not be used to make treatment or policy decisions.
More detailed information on this subject is available in “Primary Care Screening for Abdominal Aortic Aneurysm:
Evidence Synthesis,” in the USPSTF recommendation statement, and in the cost-effectiveness analyses review, which
can be found on the Agency for Healthcare Research and Quality (AHRQ) Web site (www.preventiveservices.ahrq.gov)
and through the National Guideline Clearinghouse (www.guideline.gov). The summary of evidence, recommendation
statement, and cost-effectiveness analyses review are available in print through the AHRQ Publications Clearinghouse
(1-800-358-9295, or ahrqpubs@ahrq.gov).
Screening for Abdominal Aortic Aneurysm
European Heart Journal (2001) 22, 62–72
doi:10.1053/euhj.1999.2006, available online at http://www.idealibrary.com on
Prognostic implications of intima-media thickness
and plaques in the carotid and femoral arteries in
patients with stable angina pectoris
C. Held1, P. Hjemdahl2, S. V. Eriksson1, I. Bjo¨ rkander1, L. Forslund3 and
N. Rehnqvist4
1Department of Medicine, Danderyd Hospital, 2Departments of Laboratory Medicine, Division of Clinical
Pharmacology, Karolinska Hospital, 3Department of Medicine, Trelleborg Hospital, Trelleborg and 4National
Board of Health and Welfare, Stockholm, Sweden
Background Ultrasonographic assessments of intimamedia
thickness and plaques in the carotid artery are widely
used as surrogate markers for coronary atherosclerosis, but
prospective evaluations are scarce and appear to be lacking
in patients with coronary artery disease. Ultrasonographic
evaluations of femoral vascular changes have not been
studied prospectively.
Methods and Results In the Angina Prognosis Study
in Stockholm (APSIS), 809 patients with stable angina
pectoris were studied prospectively during double-blind
treatment with verapamil or metoprolol. Ultrasonographic
assessments of intima-media thickness, lumen diameter and
plaques in the carotid and femoral arteries were evaluated
in a subgroup of 558 patients (182 females) with a mean age
of 607 years, and related to the risk of cardiovascular
death (n=18) or non-fatal myocardial infarction (n=26), or
revascularization (n=70) during follow-up (median 3·0
years). Univariate Cox regression analyses showed that
carotid intima-media thickness and plaques were related to
the risk of cardiovascular death or myocardial infarction.
Femoral intima-media thickness was related to cardiovascular
death or myocardial infarction, as well as to
revascularization, whereas femoral plaques were only
related to the latter. After adjustment for age, sex, smoking,
previous cardiovascular disease and lipid status, carotid
intima-media thickness failed to predict any cardiovascular
event, whereas carotid plaques tended (P=0·056) to predict
the risk of cardiovascular death or myocardial infarction.
Femoral intima-media thickness (P&lt;0·01) and plaques
(P&lt;0·05) were also related to the risk of revascularization
after adjustments.
Conclusions Carotid and femoral vascular changes
were differently related to cardiovascular events. Carotid
intima-media thickness was a weak predictor of events,
whereas femoral intima-media thickness predicted revascularization.
Plaques in the carotid artery were related to
cardiovascular death or non-fatal myocardial infarction,
whereas plaques in the femoral artery were related to
revascularization. Evaluations of plaques provided better
prediction than assessments of intima-media thickness in
patients with stable angina.
(Eur Heart J 2001; 22: 62–72, doi:10.1053/euhj.1999.2006)
2001 The European Society of Cardiology
Key Words: Ultrasound, carotid artery, femoral artery,
intima-media thickness, plaques, atherosclerosis, angina
pectoris, prognosis, risk factor.
See page 11 for the Editorial comment on this article
Atherosclerosis 156 (2001) 379–387
Carotid and femoral ultrasound morphology screening and
cardiovascular events in low risk subjects: a 10-year follow-up
study (the CAFES-CAVE study)
Gianni Belcaro a,b,c,*,1, Andrew N. Nicolaides c, Ganesh Ramaswami c,
Maria Rosaria Cesarone a,b, Mariateresa De Sanctis a,b, Lucrezia Incandela a,b,
Piergiorgio Ferrari d, George Geroulakos c, Antonio Barsotti a,b, Maura Griffin c,
Surinder Dhanjil c, Mike Sabetai c, Marco Bucci a, Giuseppe Martines a
a Department of Biomedical Sciences and Cardiology School, Chieti Uniersity, Chieti, Italy
b The PAP/PEA Project Institute, San Valentino (Pe), Italy
c Irine Laboratory for Cardioascular Inestigation and Research, Department of Vascular Surgery Anaestetic and Intensie Care,
St Mary’s Hospital at Imperial College, London, UK
d Crinos, Villa Guardia (Co), Italy
Received 24 March 2000; received in revised form 3 August 2000; accepted 1 September 2000
Kaplan–Meier curves illustrating the likelihood
of remaining without cardiovascular death or non-fatal
European Heart Journal (2001) 22, 62–72
doi:10.1053/euhj.1999.2006, available online at http://www.idealibrary.com on
Prognostic implications of intima-media thickness
and plaques in the carotid and femoral arteries in
patients with stable angina pectoris
C. Held1, P. Hjemdahl2, S. V. Eriksson1, I. Bjo¨ rkander1, L. Forslund3 and
N. Rehnqvist4
1Department of Medicine, Danderyd Hospital, 2Departments of Laboratory Medicine, Division of Clinical
Pharmacology, Karolinska Hospital, 3Department of Medicine, Trelleborg Hospital, Trelleborg and 4National
Board of Health and Welfare, Stockholm, Sweden
Background Ultrasonographic assessments of intimamedia
thickness and plaques in the carotid artery are widely
used as surrogate markers for coronary atherosclerosis, but
prospective evaluations are scarce and appear to be lacking
in patients with coronary artery disease. Ultrasonographic
evaluations of femoral vascular changes have not been
studied prospectively.
Methods and Results In the Angina Prognosis Study
in Stockholm (APSIS), 809 patients with stable angina
pectoris were studied prospectively during double-blind
treatment with verapamil or metoprolol. Ultrasonographic
assessments of intima-media thickness, lumen diameter and
plaques in the carotid and femoral arteries were evaluated
in a subgroup of 558 patients (182 females) with a mean age
of 607 years, and related to the risk of cardiovascular
death (n=18) or non-fatal myocardial infarction (n=26), or
revascularization (n=70) during follow-up (median 3·0
years). Univariate Cox regression analyses showed that
carotid intima-media thickness and plaques were related to
the risk of cardiovascular death or myocardial infarction.
Femoral intima-media thickness was related to cardiovascular
death or myocardial infarction, as well as to
revascularization, whereas femoral plaques were only
related to the latter. After adjustment for age, sex, smoking,
previous cardiovascular disease and lipid status, carotid
intima-media thickness failed to predict any cardiovascular
event, whereas carotid plaques tended (P=0·056) to predict
the risk of cardiovascular death or myocardial infarction.
Femoral intima-media thickness (P&lt;0·01) and plaques
(P&lt;0·05) were also related to the risk of revascularization
after adjustments.
Conclusions Carotid and femoral vascular changes
were differently related to cardiovascular events. Carotid
intima-media thickness was a weak predictor of events,
whereas femoral intima-media thickness predicted revascularization.
Plaques in the carotid artery were related to
cardiovascular death or non-fatal myocardial infarction,
whereas plaques in the femoral artery were related to
revascularization. Evaluations of plaques provided better
prediction than assessments of intima-media thickness in
patients with stable angina.
(Eur Heart J 2001; 22: 62–72, doi:10.1053/euhj.1999.2006)
2001 The European Society of Cardiology
Key Words: Ultrasound, carotid artery, femoral artery,
intima-media thickness, plaques, atherosclerosis, angina
pectoris, prognosis, risk factor.
See page 11 for the Editorial comment on this article
Vascular disease is the result of a generalized process that affects multiple vascular beds, including the cerebral, coronary, and peripheral arteries. Coexistence of vascular disease in multiple beds increases the risk for developing ischemic events such as MI and stroke.[1]
Vascular disease in cerebral arteries may precipitate a transient ischemic attack (TIA) or an ischemic stroke. A TIA, by definition, lasts for fewer than 24 hours, but the majority clear within 1 hour. A TIA may be a warning of an impending stroke, with the risk for a stroke being 4% to 8% during the first month following a TIA and 24% to 29% during the next 5 years.[2]
Vascular disease in coronary arteries produces a spectrum of ischemic coronary syndromes that include stable angina, unstable angina, non–ST-segment elevation myocardial infarction (NSTEMI; also known as non–Q-wave MI), and ST-segment elevation (STEMI; also known as Q-wave MI). Cardiovascular disease is the single largest cause of death in the United States.[3]
Vascular disease in peripheral vessels, peripheral arterial disease (PAD), produces a variety of symptoms ranging from intermittent claudication to pain at rest.[4] Patients with the most serious PAD have critical limb ischemia that produces pain at rest and threatens the viability of the limb by increasing the risk for gangrene and necrosis.[4] PAD is a strong marker for cardiovascular disease. Over a 10-year period, PAD increases risk for death due to cardiovascular disease approximately 6-fold.[5]
Note: Plavix® (clopidogrel) is not indicated for all the conditions listed on this slide.
Unadjusted Cumulative Event-free Rates for the Combined End Point of Myocardial Infarction or Stroke, According to Quintile of Combined Intima–Media Thickness.
The estimated cumulative rate of the combined end point for the fifth quintile of the combined measure was over 25 percent at seven years, as compared with a cumulative rate of less than 5 percent for the first quintile.
&apos;Leary et al. 340 (1): 14, Figure 1 January 7, 1999
Survival curves for no, mild, moderate, and severe atherosclerosis as indicated by the composite atherosclerosis score. Analyses were adjusted for age and gender.
Background— Several noninvasive methods are available to investigate the severity of extracoronary atherosclerotic disease. No population-based study has yet examined whether differences exist between these measures with regard to their predictive value for myocardial infarction (MI) or whether a given measure of atherosclerosis has predictive value independently of the other measures.
Methods and Results— At the baseline (1990–1993) examination of the Rotterdam Study, a population-based cohort study among subjects age 55 years, carotid plaques and intima-media thickness (IMT) were measured by ultrasound, abdominal aortic atherosclerosis by x-ray, and lower-extremity atherosclerosis by computation of the ankle-arm index. In the present study, 6389 subjects were included; 258 cases of incident MI occurred before January 1, 2000. All 4 measures of atherosclerosis were good predictors of MI independently of traditional cardiovascular risk factors. Hazard ratios were equally high for carotid plaques (1.83 [1.27 to 2.62], severe versus no atherosclerosis), carotid IMT (1.95 [1.19 to 3.19]), and aortic atherosclerosis (1.94 [1.30 to 2.90]) and slightly lower for lower-extremity atherosclerosis (1.59 [1.05 to 2.39]), although differences were small. The hazard ratio for MI for subjects with severe atherosclerosis according to a composite atherosclerosis score was 2.77 (1.70 to 4.52) compared with subjects with no atherosclerosis. The predictive value of MI for a given measure of atherosclerosis was independent of the other atherosclerosis measures.
Conclusions— Noninvasive measures of extracoronary atherosclerosis are strong predictors of MI. The relatively crude measures directly assessing plaques in the carotid artery and abdominal aorta predict MI equally well as the more precisely measured carotid IMT
Carotid Intima-Media Thickness, Plaques, and Framingham
Risk Score as Independent Determinants of Stroke Risk
Pierre-Jean Touboul, MD; Julien Labreuche, BS; Eric Vicaut, MD, PhD; Pierre Amarenco, MD; on
behalf of the GENIC Investigators*
Background and Purpose—The Framingham stroke risk score (FSRS) and Framingham cardiovascular risk score (FCRS)
estimate the individual absolute cardiovascular and stroke risks. Common carotid artery intima-media thickness
(CCA-IMT) and carotid plaques (CPs) are markers of subclinical atherosclerosis and help in the early identification of
presymptomatic individuals. The purpose of this study was to correlate Framingham risk score (FRS) with CCA-IMT
and CPs and evaluate their respective contribution to stroke risk.
Methods—In 510 consecutive patients with brain infarction and 510 matched controls, we calculated the FSRS and FCRS
for each individual and performed carotid ultrasonography. Mean CCA-IMT was measured off-line at a central core
laboratory, and presence of CPs was assessed.
Results—FRS progressively increased according to tertiles of CCA-IMT (P for trend 0.0001). The part of the variances
of FSRS and FCRS explained by CCA-IMT was respectively 11% and 20%. The relationships between CCA-IMT and
FRS were significantly different between patients with or without CPs (P for interaction 0.005). With increasing
CCA-IMT, the 10-year FRS gradually increased between 10% and 20% in the presence of CPs and between 5% and
20% in the absence of CPs. Multiple conditional logistic regression for matched sets showed that CCA-IMT, FCRS, and
CPs were independently associated with stroke risk, with an odds ratio of 1.68 (1.25 to 2.26; P0.0006), 2.16 (1.57 to
2.98; P0.0001), and 2.73 (1.68 to 4.44; P0.0001), respectively, meaning that each of them may be important for
evaluation of the individual cardiovascular risk.
Conclusions—CCA-IMT, CPs, and FRSs correlated well. The CCA-IMT value may help discriminate between subjects
at low or high 10-year risk. (Stroke. 2005;36:1741-1745.)